POPULARITY
Categories
This episode unpacks the unique challenges faced by women leaders, their contributions to democracy, and the critical lessons they offer in the fight against authoritarianism. Enter the CFR book giveaway by July 8, 2026, for the chance to win one of ten free copies of Women in Power by Linda Robinson. You can read the terms and conditions of the offer here. Host: James M. Lindsay, Mary and David Boies Distinguished Senior Fellow in U.S. Foreign Policy, CFR Guest: Linda Robinson, Senior Fellow for Women and Foreign Policy, CFR; Author, Women in Power: Fighting for Democracy in an Age of Authoritarianism We Discuss: Why women's political representation has stalled at roughly 27 percent in the world's legislatures. How right-wing authoritarianism and the normalization of violent misogyny have combined to create ferocious headwinds for women in politics. Whether women govern differently from men, and what the research reveals about their attentiveness to health, education, welfare, and climate issues. Why rolling back women's rights is central to authoritarian and right-wing movements, and why playing the "misogyny card" proves so effective, even among women voters. Why some of the most prominent nationalist movements—in Italy, France, and Germany—are led by women, and how right-leaning figures like Giorgia Meloni complicate the picture. How authoritarian governments use hybrid warfare and gendered disinformation against women leaders, including Chinese campaigns against Taiwan's Tsai Ing-wen and Russian campaigns against Moldova's Maia Sandu. Which common themes emerge among successful women leaders. Which policy reforms could strengthen both democracy and women's political participation. Mentioned on the Episode: Linda Robinson, Women in Power: Fighting for Democracy in an Age of Authoritarianism, Columbia University Press Sanna Marin, Hope in Action: A Memoir About the Courage to Lead, Scribner “Freedom in the World 2026: The Growing Shadow of Autocracy,” Freedom House “Expanding Representation: Reinventing Congress for the 21st Century,” American Academy of Arts and Sciences “TAKE IT DOWN Act (S.146),” U.S. Congress “The Digital Services Act,” European Commission “First Five,” HBO Max For an episode transcript and show notes, visit The President's Inbox at: https://www.cfr.org/podcasts/presidents-inbox/women-in-power Opinions expressed on The President's Inbox are solely those of the host or guests, not of CFR, which takes no institutional positions on matters of policy.
For many families, water represents joy, summer afternoons, swimming lessons, beach vacations, backyard pools and time spent together. But in pediatrics, we also know that water can become dangerous in seconds, often quietly and without warning. Drowning remains one of the leading causes of preventable death in children, and recent updates from the American Academy of Pediatrics reinforce that prevention must be layered, proactive and tailored. In this episode, we explore how pediatricians can support drowning prevention, because some of the most important work in pediatrics happens long before an emergency occurs. We are joined by Jason Woods, MD. He specializes in emergency medicine at Children's Hospital Colorado and is the Associate Program Director of the Pediatric Emergency Medicine Fellowship Program at the University of Colorado School of Medicine. He is also an associate professor. Some highlights from this episode include: The AAP guidelines and toolkit details about drowning prevention Why the definition of drowning has changed and why that matters How drowning prevention is layered The role of the pediatrician in feeling confident to counsel families on this topic For more information on Children's Colorado, visit: childrenscolorado.org.
In this Q&A episode of our pediatric neurology series, we answer listener questions about some of the most rapidly evolving areas in neurology and genetics. The discussion begins with the relationship between child abuse evaluations and Brief Resolved Unexplained Events (BRUE), including important considerations when assessing infants with unexplained symptoms.Host Paul Wirkus, MD, FAAP and guest Josh Bonkowsky, MD then explore the neurologic basis of developmental disorders and the growing role of advanced diagnostics such as genome sequencing and MRI. Our guests discuss how these tools can provide valuable insights into underlying conditions and increasingly influence treatment decisions and long-term care planning.The conversation also examines the complex relationship between genes, brain development, and the symptoms children experience. As genetic testing becomes more widely available, we consider the promise of gene therapy, the emerging field of precision medicine, and realistic timelines for translating these advances into everyday clinical practice. Finally, we discuss the benefits of obtaining a genetic diagnosis-even when a cure is not yet available-including connecting families with resources, reducing isolation, informing future care decisions, and the potential expansion of newborn screening programs as genetic therapies continue to develop.Have a question? Email questions@vcurb.com. Listener questions will be answered in episode four. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP. Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Photo by Ashley Walker on Unsplash Sudden infant death syndrome, or SIDS, is the unexplained death of a healthy baby, usually before their first birthday, that often occurs during sleep. It's also been called crib death, and is a leading cause of death in infants. One of the strategies that the United States has used to try to reduce these deaths is to tell new mothers not to sleep with their babies, under the assumption that thebaby could be unintentionally smothered by the mother during sleep. This has been the recommendation of the American Academy of Pediatrics for some years now, but one nurse scientist is challenging this recommendation. Dr. LaurenCovington, PhD, RN, is an Assistant Professor at the University of Delaware School of Nursing, a sleep health equity researcher and a practicing pediatric ICU nurse with over 15 years of experience. She has received numerous national and local awards for her research on improving sleep and health outcomes in socioeconomically disadvantaged families. She spoke with HealthCetera host, Diana Mason, PhD, RN, about SIDS and her work on this important health issue. This interview first aired on HealthCetera in the Catskills on WIOX Radio on May 27, 2026. The post Reducing Crib Death appeared first on HealthCetera.
I am delighted to have Dr. Ken Berry returning to the podcast for his fourth appearance today. He is a physician, bestselling author, and passionate advocate for health, known for his no-nonsense approach to wellness. Dr. Berry has practiced at the Berry Clinic since 2003 and is an active community member. He has a YouTube channel with more than 2 million subscribers- one of my favorite go-to resources for patients. In our discussion today, we explore a recent Time news article and the growing concerns around the declining trustworthiness of media sources. We dive into the limitations of observational research, the problem with celebrity endorsements of ultra-processed foods, rising obesity rates in children and teens, and whether genetic factors are actually behind obesity, as highlighted recently in a 60 Minutes segment. We also discuss the impact of sugar, grains, and seed oils, as well as the significance of visceral fat. You will not want to miss this invaluable discussion with Dr. Ken Berry. IN THIS EPISODE YOU WILL LEARN: Dr. Berry breaks down some deeper issues surrounding the recent Time article, where a lone registered dietitian claimed that ultra-processed foods are acceptable. How media sources are losing their credibility The vital part social media plays in changing the narrative and holding media sources accountable Why consumers must stay informed and be proactive in their health choices The health implications of eating ultra-processed foods Dr. Berry shares his concerns about the American Academy of Pediatrics recommending drugs like Ozempic for children. The benefits of eating whole foods Dr. Berry shares his three rules for a healthy diet. Why we need to avoid sugar and seed oils How following a low-carb diet can help reduce visceral fat. Dr. Berry introduces the American Diabetes Society and explains its mission. Bio: Dr. Ken D. Berry, MD, is a licensed family physician, best-selling author, and leading advocate for the Proper Human Diet (PHD). With over two decades of clinical experience, Dr. Berry specializes in helping patients improve their health through low-carbohydrate, nutrient-dense eating. His best-selling book, "Lies My Doctor Told Me: Medical Myths That Can Harm Your Health," and his popular YouTube channel, which has over 3 million subscribers, provide accessible, evidence-based guidance on nutrition and wellness. Dr. Berry's mission is to empower individuals to reclaim their health by debunking common medical myths and promoting sustainable dietary and lifestyle changes. He is also a member of the Diet Doctor low-carb expert panel and an active participant in the keto and low-carb communities. Dr. Berry lives with his wife Neisha and their children on a farm in Holladay, Tennessee. Connect with Cynthia Thurlow Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow. Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Ken Berry On his website YouTube Dr. Berry's Books The American Diabetes Society
In this two-hour roundtable recorded at a global airway, breathing, and sleep conference, Howard Farran sits down with three of the field's most passionate voices: Dr. Toshi Hart, Diplomate and President-Elect of the American Sleep and Breathing Academy; Dr. Kimberly Ann Meyer, current President of the American Academy of Craniofacial Pain; and Dr. Mark Levi, a Sydney-based diplomate who turned his own severe sleep apnea diagnosis into a career treating children. The conversation centers on a provocative idea: that the malocclusion, crowded teeth, and breathing problems flooding modern dental practices stem from generations of underdeveloped jaws — driven by softer diets, less nursing, and mouth breathing. Dr. Hart shares how a single 45-minute lecture on craniofacial epigenetics redirected her career, leading to a study in which guided growth appliances produced a 76% reduction in decay. Dr. Levi makes the case for early intervention in children as young as three, explaining why the window to influence facial growth closes far earlier than most clinicians realize. Dr. Meyer connects the dots between nasal breathing, nitric oxide, tongue posture, tonsils and adenoids, and the cascade of downstream effects on sleep, behavior, and long-term health. Along the way, the group tackles the fierce professional pushback they face, why mothers — not journals — are driving change, the relationship between bruxism, airway, and even implant failure, and how a single-chair, drill-free practice can outperform a traditional one. The episode closes with practical guidance for young dentists on where to begin, why education matters more than expensive machinery, and how building thriving children builds a thriving practice. Episode #1709 : Dentistry Uncensored with Howard Farran, Howard sits down with a powerhouse airway roundtable — Dr. Toshi Hart, Dr. Kimberly Ann Meyer, and Dr. Mark Levi — three leaders changing how dentistry thinks about jaw development, breathing, and sleep. From why 80% of kids have underdeveloped jaws, to a 76% reduction in decay through early intervention, to the pushback these "myofunctional quacks" proudly embrace — this is a candid, eye-opening conversation about treating the root cause, not just the cavity.
In this episode of Hunger for Wholeness, Ilia Delio speaks with scholar Robert Geraci about apocalyptic AI, robotics, transhumanist hope, and the religious stories embedded in technological imagination. Geraci traces how his study of robotics led him to notice strikingly religious themes in the writings of engineers and futurists: immortality, resurrection, salvation, and the future transformation of humanity.Together, Ilia and Robert explore the mid-20th-century roots of computer intelligence, the shadow of world war, and the deep eschatological hopes and fears that shaped early conversations about machines, minds, and human destiny. They consider how figures such as Hans Moravec, Ray Kurzweil, J. B. S. Haldane, Julian Huxley, Norbert Wiener, and Alan Turing reveal the religious imagination at work within technological culture.Later in the episode, the conversation turns toward technology, ecology, and responsibility. Rather than treating technology as the enemy, Ilia and Robert ask how human beings might reclaim the deeper narratives, values, and forms of belonging needed to guide technological development toward the flourishing of the whole Earth community.ABOUT ROBERT GERACIRobert M Geraci is the Knight Distinguished Chair for the Study of Religion & Culture at Knox College. His research explores religion, science and technology in the contemporary world. He is the author of Apocalyptic AI: Visions of Heaven in Robotics, Artificial Intelligence, and Virtual Reality (Oxford 2010), Virtually Sacred: Myths and Meaning in World of Warcraft and Second Life (Oxford 2014), Temples of Modernity: Nationalism, Hinduism, and Transhumanism in South Indian Science (Lexington 2018), Futures of Artificial Intelligence: Perspectives from India and the U.S. (Oxford 2022), and Futureproofing Humanity: Existential Risk and the Technomyths of Human Engineering, Artificial Intelligence, and Our Future among the Stars (self 2026). He has been a visiting researcher at Carnegie Mellon University's Robotics Institute, the Indian Institute of Science and the National Institute for Advanced Studies in Bangalore, India. His research has been supported by the US National Science Foundation, the Republic of Korea National Research Foundation, the American Academy of Religion and two Fulbright-Nehru research awards. He enjoys kayaking, hiking, videogames, and Dungeons & Dragons but doesn't really have time for any of it. Join us for the Center's 10th Anniversary Conference, November 9–11 in Villanova, Pennsylvania, with a virtual option available. In a time of deep political, social, ecological, and spiritual division, this gathering explores how love can become a compass for transformation. Learn more and register at christogenesis.org/conference. We are currently in the midst of our summer fundraiser, From Fear to Hope: Change and the Perpetual Growth of Life. As the Center marks its tenth anniversary, your support sustains our conferences, webinars, publications, and emerging global learning platform. Please consider making a generous contribution at christogenesis.org/donate.Support the showA huge thank you to all of you who subscribe and support our show! Support for A Hunger for Wholeness comes from the Fetzer Institute. Fetzer supports a movement of organizations who are applying spiritual solutions to society's toughest problems. Get involved at fetzer.org.Visit the Center for Christogenesis' website at christogenesis.org/podcast to browse all Hunger for Wholeness episodes and read more from Ilia Delio. Follow us on Facebook and Instagram for episode releases and other updates.
In the U.S., someone dies from heart disease every 33 seconds. Men face a higher risk, yet many are reluctant to see a doctor for regular screenings. I spoke with Dr. Jane Wilcox, associate chief of cardiology at Northwestern Medicine, about why Father's Day is the perfect time to encourage dad to take care of his heart health. AND, raising a kid in this day and age is arguably more difficult than it has ever been. Whether it is screen time or social media, to on-line bullying and AI porn leading to unhealthy sleep and body-image issues, to depression......or even suicide. I discussed it all with Dr. Tiffany Munzer, the lead author on our digital ecosystem policy for the American Academy of Pediatrics.See omnystudio.com/listener for privacy information.
Welcome to The Mental Breakdown and Psychreg Podcast! Today, Dr. Berney and Dr. Marshall discuss Parental Alienation, including what it is, why it is so difficult to identify, and the long term consequences it has on the kids and the parents. Read the articles from Psychology Today here and from the Journal of the American Academy of Child and Adolescent Psychiatry here. You can now follow Dr. Marshall on twitter, as well! Dr. Berney and Dr. Marshall are happy to announce the release of their new parenting e-book, Handbook for Raising an Emotionally Healthy Child Part 2: Attention. You can get your copy from Amazon here. We hope that you will join us each morning so that we can help you make your day the best it can be! See you tomorrow. Visit Psychreg for blog posts covering a variety of topics within the fields of mental health and psychology. The Parenting Your ADHD Child course is now on YouTube! Check it out at the Paedeia YouTube Channel. The Handbook for Raising an Emotionally Health Child Part 1: Behavior Management is now available on kindle! Get your copy today! The Elimination Diet Manual is now available on kindle and nook! Get your copy today! Follow us on Twitter and Facebook and subscribe to our YouTube Channels, Paedeia and The Mental Breakdown. Please leave us a review on iTunes so that others might find our podcast and join in on the conversation!
This surprising claim was spotted circulating on social media: ‘The United States has surpassed China and North Korea in deaths from malnutrition'. The claim used analysis from the Global Burden of Disease database for their sums. The data does indeed show that the US records more deaths from Malnutrition than China and North Korea. The rate in the US was 2.8 deaths per 100,000 compared to just 1.7 deaths per 100,000 for North Korea. From what we know about the two countries this seems unlikely, so what's going on here? We talk to Dr Krstina Newport, Chief Medical officer for the American Academy of Hospice and Palliative Care Medicine to find out more.If you've seen a number in the news you think we should take a look at, email moreorless@bbc.co.uk Presenter: Tim Harford Producer: Lizzy McNeill Series Producer: Tom Colls Editor: Richard Vadon Production Coordinator: Brenda Brown Sound Mix: Duncan Hannant
THE EMBC NETWORK featuring: ihealthradio and worldwide podcasts
353. A MAN BECOMES WHAT HE THINKS ABOUT MOST OF THE TIME --Ralph Waldo Emerson ROBERT A. YOHO, MD. President, American Society of Cosmetic Breast Surgery, 2012-2013. Fellow, American Society of Cosmetic Breast Surgery. Passed specialty boards of American Board of Dermatologic Cosmetic Surgery and the American Board of Laser Surgery. Fellow of American Academy of Cosmetic Surgery and American Society of Cosmetic Breast Surgery. California Academy of Cosmetic Surgery, past board member. BIoidentical Hormone Therapy, WorldLinkMedical. Emergency Medicine Board Certified and recertified. AUTHOR: A New Body in One Day. Published over 20 articles for physicians in medical journals. CLIMBER. 24 hour ascents of both El Capitan and Half Dome. Free ascents Astroman, Crucifix. First ascents Yosemite, Joshua Tree, Devils Tower. EAGLE SCOUT. TRIATHLON participant and age group winner. Founder & Director NEW BODY COSMETIC SURGERY ~ Accreditation Association Ambulatory Health Care (AAAHC) Certified & Accredited Surgical/Medical Practice & New Body Cosmetic Surgery DrYoho.com Support the show
THE EMBC NETWORK featuring: ihealthradio and worldwide podcasts
353. A MAN BECOMES WHAT HE THINKS ABOUT MOST OF THE TIME --Ralph Waldo Emerson ROBERT A. YOHO, MD. President, American Society of Cosmetic Breast Surgery, 2012-2013. Fellow, American Society of Cosmetic Breast Surgery. Passed specialty boards of American Board of Dermatologic Cosmetic Surgery and the American Board of Laser Surgery. Fellow of American Academy of Cosmetic Surgery and American Society of Cosmetic Breast Surgery. California Academy of Cosmetic Surgery, past board member. BIoidentical Hormone Therapy, WorldLinkMedical. Emergency Medicine Board Certified and recertified. AUTHOR: A New Body in One Day. Published over 20 articles for physicians in medical journals. CLIMBER. 24 hour ascents of both El Capitan and Half Dome. Free ascents Astroman, Crucifix. First ascents Yosemite, Joshua Tree, Devils Tower. EAGLE SCOUT. TRIATHLON participant and age group winner. Founder & Director NEW BODY COSMETIC SURGERY ~ Accreditation Association Ambulatory Health Care (AAAHC) Certified & Accredited Surgical/Medical Practice & New Body Cosmetic Surgery DrYoho.com Support the show
Description: Do you wonder if TB testing is needed when on a biologic for psoriasis and/or psoriatic arthritis and why? Hear the answer to such questions and more from dermatologist Dr. G. Scott Drew as he addresses recent recommendations. Join host Archie Franklin as he discusses the latest recommendations from NPF and the International Psoriasis Council about routine testing for tuberculosis (TB) with treatments for psoriasis and psoriatic arthritis such as TNF-inhibitors, IL-17's, IL-23's and others with NPF Medical Board member and leading dermatologist Dr. G. Scott Drew from Mid-Ohio Dermatology. This episode identifies when a screening for tuberculosis (TB) is needed based on the type of treatment for psoriasis and psoriatic arthritis given recent recommendations from the National Psoriasis Foundation and the International Psoriasis Council. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. G. Scott Drew. (1:00) What is tuberculosis (TB) and why testing is required with TNF-alpha inhibitors. (4:22) Frequency of testing for TB and if false positive results occur. (6:15) Do other immunosuppressants require TB testing? (8:14) Testing may create barriers to access or unnecessary testing. (11:03) Release of new recommendations from the IPC and the NPF Medical Board offering guidance of when to test for tuberculosis prior to and during treatment of psoriatic disease. (15:37) No longer need to wait to start therapy like the IL-17's or IL-23's to see the impact on quality of life. (18:26) TB recommendations for other targeted medications like JAK inhibitors, PDE4, or the new oral IL-23 agent. (19:15) Implications of the recommendations for clinical trials. (20:13) Become a member of NPF and visit the website to access resources and stay aware of the latest information impacting the care and treatment of psoriasis and psoriatic arthritis. Key Takeaways: · Due to the contagious nature of tuberculosis, a mycobacteria infection that affects the lungs and other parts of the body, and the increased risk associated with suppressing TNF-alpha, a TB screening is required prior to initiating and during some treatments for psoriasis and psoriatic arthritis. · With more advanced and targeted psoriatic disease treatments now available, the National Psoriasis Foundation and the International Psoriasis Council joint position statement recommends that TB screening is no longer needed with use of IL-17 or IL-23 treatments. · TB screening may still be appropriate for specific populations and when symptoms are present based on a clinician's assessment. Guest Bio: Dr. G. Scott Drew is a medical and surgical dermatologist with Mid-Ohio Dermatology Associates where he specializes in inflammatory diseases such as psoriasis, believing strongly in dermatology and patient care. He is board certified in both Dermatology and Family Practice. In addition to his clinical practice, Dr. Drew is a member of the clinical faculty at Ohio State University, College of Osteopathic Medicine and participates in multiple dermatologic research protocols at five locations in central Ohio. He has been published in numerous peer-reviewed journals, contributed to scientific symposia, and authored textbook chapters. Dr. Drew is a fellow of the American Osteopathic College of Dermatology and the American Academy of Dermatology, he is past president of the Marion Academy of Medicine, a member of the American Osteopathic Association, and is a member of the National Psoriasis Foundation's Medical Board contributing to the development of guidelines and consensus statements. He is passionate about education providing lectures both nationally and internationally on medical, surgical, and cosmetic dermatology. Resources: Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors. Journal of the American Academy of Dermatology. Vol . 94/3; P802-809. March 2026.
In this week's episode, Jess chats with Dr. Sarah Nosal to discuss the importance of adult vaccines, including shingles, HPV, flu, COVID, RSV, and more. They cover vaccine recommendations, personal experiences, and address common questions to help listeners make informed health decisions. We'd like to thank the American Academy of Family Physicians for sponsoring today's episode and helping us bring awareness to adult vaccines! Watch the convo on YouTube: https://youtu.be/QKpau8xcMTk (00:00) Intro & Public Health Update (04:12) Shingles Vaccine (11:37) HPV Vaccine (18:35) Flu Vaccine (25:23) COVID Vaccine (27:19) RSV Vaccine (30:15) Meningitis Vaccine (31:19) Chicken Pox/Varicella Vaccine (32:22) Adult Boosters For Childhood Vaccines (34:29) Vaccination During Pregnancy (36:09) Is There An Adult Vaccine Schedule? (38:39) First Time Grandparent Vaccine Recommendations (39:38) Final Thoughts https://www.acog.org/clinical-information/maternal-immunization-schedule https://www.aafp.org/about/leadership/board/sarah-nosal https://www.aafp.org/clinical-insights/immunizations-and-vaccines/immunizations-schedules-resourceshhttps://familydoctor.org/the-importance-of-vaccinations/ https://familydoctor.org/vaccines-myth-versus-fact/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Send us Fan MailAccording to the American Academy of Pediatrics, more than 50% of transgender boys have attempted suicide. Directors Lexie and Logan travel across the United States, trying to understand their own trans boyhood through the legacies of two young men and exploring what community healing means. From World preimere Berlinale (winning two awards incl the Amnesty International Film Award for best human rights project) to UK Premiere at BFI Flare (named amongst top films to watch from Time Out London, Criterion Collection, Pink News, and Buzzfeed)top indie fests in Asia and other notable LGBT fests around Europe, just winning the Audience Award in SwitzerlandIn lead up to North American screenings Inside Out (Canada's largest queer fest) and bring in Pride Month with deadCenter in Oklahoma CityLexie Bean (they/he) Perigee Vitz-WongWebsite | Rotten Tomatoes | Linktree | Youtube | Twitter | Instagram
Many people worry about memory loss and cognitive decline as they age. In this episode of Health Matters, host Courtney Allison speaks with Dr. Matthew Fink, neurologist-in-chief at NewYork-Presbyterian and Weill Cornell Medicine, about how lifestyle choices—especially diet—can help protect the brain. Dr. Fink explains the MIND diet, a combination of the Mediterranean and DASH diets, which emphasizes whole foods like leafy greens, berries, fish, nuts, and olive oil while limiting salt, sugar, and ultra-processed foods. He breaks down how key nutrients such as B vitamins and antioxidants support brain metabolism, reduce inflammation, and may slow the aging process. The conversation also highlights the brain's high energy demands and why proper nutrition is essential for cognitive function. Dr. Fink shares research showing that healthy lifestyle interventions can significantly lower the risk of dementia and discusses the broader benefits of the MIND diet for heart health and stroke prevention. Finally, Dr. Fink outlines additional habits that support brain health, including regular physical activity, quality sleep, and social connection, emphasizing that even small, gradual changes can lead to meaningful long-term benefits. Chapters 00:00 – Why Brain Health Is in Your Control How lifestyle choices can reduce dementia risk and why prevention starts early 03:00 – What Is the MIND Diet? Key components of the Mediterranean and DASH diets and how they support the brain 06:00 – Brain-Boosting Nutrients and Foods to Avoid The role of B vitamins, antioxidants, and which foods increase risk 10:30 – Beyond Diet: Exercise, Sleep, and Daily Habits How movement, rest, and social connection contribute to cognitive health Key Topics Covered MIND diet overview Mediterranean diet and DASH diet Brain metabolism and energy use B vitamins and brain health Antioxidants and inflammation Foods that support cognitive function Foods to limit (salt, sugar, processed foods) Dementia and Alzheimer's prevention Stroke and heart disease connection Exercise and brain function Sleep and cognitive health Lifestyle changes for healthy aging Takeaway Message You have more control over your brain health than you might think. By focusing on whole, nutrient-rich foods, limiting processed options, staying active, and getting enough sleep, you can significantly reduce your risk of cognitive decline and support a healthier brain as you age. Doctor Bios Matthew E. Fink, MDis currently the Louis and Gertrude Feil Professor and chair of the Department of Neurology at Weill Cornell Medicine, and neurologist-in-chief at NewYork Presbyterian/Weill Cornell Medical Center. In addition, he is chief of the Division of Stroke and Critical Care Neurology at NewYork-Presbyterian/Weill Cornell Medical Center, and vice chair of the medical board. Dr. Fink attended college at the University of Pennsylvania, medical school at the University of Pittsburgh, and served as resident and chief resident in internal medicine at the Boston City Hospital. He came to New York and trained in neurology at the Neurological Institute of NewYork-Presbyterian/Columbia University Irving Medical Center, and served as chief resident under Dr. Lewis P. Rowland. Subsequently, he joined the faculty of Columbia University and became the founding director of the Neurology-Neurosurgery Intensive Care Unit at NewYork-Presbyterian and was appointed associate professor of clinical neurology and neurosurgery while at Columbia. Dr. Fink was a founding member and chair of the critical care section of the American Academy of Neurology, and the research section for neurocritical care of the World Federation of Neurology. He is board-certified in internal medicine, neurology, critical care medicine, vascular neurology, and neurocritical care. He has been elected as a Fellow of the American Neurological Association, the American Academy of Neurology, and the Stroke Council of the American Heart Association. Throughout his career, Dr. Fink has been involved in the education and training of students, residents and fellows in the field of stroke and critical care neurology, as well as an active participant in clinical research within this field. He is a leader in this new specialty, has lectured widely, and has published many research and clinical articles in the field of stroke and critical care. In addition, he currently serves as editor of the monthly publication, NEUROLOGY ALERT, and is a past-president of the New York State Neurological Society.
Primary stroke prevention is a critical opportunity for neurologists, with most stroke risk driven by modifiable factors such as hypertension and lifestyle behaviors. This episode highlights practical tools and strategies, including Life's Essential 8 and contemporary risk calculators, while also exploring evolving approaches to shared decision making and secondary prevention. In this episode, Katie Grouse, MD, FAAN, speaks with Mitchell S. Elkind, MD, MS, FAAN, author of the article "Stroke Prevention" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California, San Francisco in San Francisco, California. Dr. Elkind is the Chief Science Officer for Brain Health and Stroke at the American Heart Association in Dallas, Texas, and a professor of neurology and epidemiology at Columbia University in New York, New York. Additional Resources Read the article: Stroke Prevention Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @MitchElkind Full episode transcript available here Dr Grouse: Neurologists have generally been more involved in secondary stroke prevention, but primary stroke prevention is increasingly recognized as an important topic of discussion for neurologists. Today, I have the opportunity to interview Dr. Mitchell Elkind, who wrote the article on stroke prevention in the newest Continuum issue on cerebrovascular disease. Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr. Katie Grouse. Today, I'm interviewing Dr. Mitchell Elkind about his article on stroke prevention. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast, and please introduce yourself to the audience. Dr Elkind: Thank you so much, Katie. So, my name is Mitch Elkind, and I'm the Chief Science Officer for Brain Health and Stroke at the American Heart Association and a stroke neurologist by background. Dr Grouse: Well, I just want to start by saying that I really enjoyed reading this article. I think this is just a really wonderful article I recommend strongly. Such a high yield, an important topic for a lot of us who see patients who are interested in learning about their stroke risks or need help with, uh, stroke prevention after having a stroke. So, I wanted to start. What's changed in the last couple of years? You know, what are some big highlights that you really want to stress that are different from maybe the last time we reviewed this topic? Dr Elkind: Sure. Well, there's been a lot of development in the field of secondary stroke prevention, for one thing. But even beyond that, I think we increasingly appreciate how important it is to control what we call the social drivers of health on the earlier side, primordial or primary prevention. And that has been a big advance, I'd say. And I would also say, I think it's really important for neurologists to understand some of those questions about primordial and primary prevention. You know, we tend to get involved with patients after they've had a stroke or maybe a TIA, some kind of event. But sometimes we find people who are following for, you know, non-stroke related conditions who have risk factors also. And we can really play an important role in identifying those risk factors and helping to prevent a first stroke or vascular event as well. So, I think it's real important for us to be doctors even before we're neurologists. So, you know, Katie, about ninety percent of stroke risk is modifiable, so we can do a great job as neurologists in preventing stroke. And one of the most important things that we can do is to identify and treat high blood pressure. And recently, actually, the American Heart Association, American College of Cardiology guidelines on the management of hypertension have said that treatment of high blood pressure not only prevents stroke, but it can also help to prevent cognitive decline and dementia. And this is the first time that we've had a class of recommendation one and level of evidence A, the highest level of recommendation we give for the use of blood pressure treatment to prevent dementia. And that's largely based on the results of some large trials that have come out recently showing that you can prevent dementia with blood pressure control. So that's a really exciting link, I think, between cardiovascular risk factor control and subsequent brain health. It just illustrates the role that neurologists can play in, so many conditions outside of stroke as well. Dr Grouse: That's a really great point, and I want to get a little more into the idea of primordial stroke prevention. Can you tell us a little bit more about what that might be? Dr Elkind: So primordial prevention refers to addressing how we can prevent risk factors from occurring in the first place, and how can we improve the environments in which people live. You know, we know that only about twenty percent of health outcomes is dependent on what happens between the patient and their doctor in the office. About eighty percent of it is due to what happens in the environments in which we live, work, pray, and play. And so that's what we mean when we refer to the social drivers of health. What is the neighborhood like where somebody lives? Do they have access to healthy food? Do they have places where they can go to exercise? Is there air pollution in the area that may affect their health? You know, one really interesting fact that's become apparent in the last few years is that air pollution is a major risk factor for stroke. Something like a sixth of all strokes can be attributed to the quality of air. And so, what are the things we can do at the broader public policy, community level to reduce the risk of risk factors like high blood pressure and diabetes even before somebody has an event that brings them to the attention of the doctor? So that's what we're thinking about with regard to primordial prevention. It's the earliest stage in prevention. Dr Grouse: And that's really fascinating. You know, I think an area that we haven't, as neurologists, really put a lot of our time thinking about, but clearly a very important thing. I really appreciated reading your article about how you incorporated the fact that, you know, a lot of these risk factors overlap very, very closely with all the risk factors for various types of cardiovascular events. And I would imagine that the work you've done as the Chief Clinical Science Officer for the American Heart Association has informed a lot of the way you've thought about-Trying to bring all these risks together and think a little bit more holistically about the whole thing. Could you tell us a little bit more about that and the work that you've done on the American Heart Association's Life's Essential 8 score? Dr Elkind: Sure. I can't take credit for it. It's really work that was done by others at the Heart Association, particularly a cardiologist and epidemiologist named Don Lloyd-Jones. But many other volunteers participated. Life's Essential 8 is our approach to primary stroke prevention and cardiovascular prevention more broadly. We say Life's Essential 8 because it includes four health behaviors and four health factors that people can observe to reduce their risk of cardiovascular disease. The four factors are kind of things like know your numbers, your blood pressure, your blood sugar, your body mass index, right, which is a combination of weight and height, and your cholesterol level. So, know those numbers and keep them within the recommended ranges, and talk to your doctor if they're not. And then four lifestyle behaviors. So, one of them is to eat a healthy diet, and typically that means the Mediterranean diet. It means getting regular exercise, and we recommend 150 minutes a week of moderate to vigorous physical activity. Of course, it means abstinence from smoking or other tobacco products. And the last one, the eighth one, which I was so excited about when we added this, is sleep, recommending at least seven hours of sleep a night. So, I was really excited about this because we used to talk about Life's Simple 7, and then the last iteration of our recommendations included this recommendation for adequate sleep because of the mounting evidence of the importance of sleep to cardiovascular health. But sleep is really a brain function, right? And so, it was really the first, in a way, specific brain function that was added to our recommendations. So that's Life's Essential 8. People can read about it online at heart.org and recommend it to your patients as a simple way for people to understand the best approach to reducing their risk of cardiovascular disease, including stroke. Dr Grouse: I checked it out myself after reading the article. It's very accessible to patients. It's a great education tool. And they can, you know, see their own score and use that in their own way to, to think about what their risks are and how they can help mitigate and then rescore themselves down the line. There's also, though, on the kind of more the clinician side, the PREVENT calculator as well. Could you tell us a little bit more about how we could use that in approaching this patient population? Dr Elkind: Yeah. So, I think of Life's Essential 8 as being a patient-focused tool that people can use. PREVENT is really more for clinicians. Anybody can look it up online and enter your data into it. There's a risk calculator online. But the basic idea behind PREVENT and other similar risk calculators is that it's a way to estimate somebody's risk of having a cardiovascular event like stroke or a heart attack or even heart failure by entering information about your health. And we used to think, we used to use something called the ASCVD, atherosclerotic cardiovascular disease risk calculator, or the Framingham score. Framingham Heart Score, for example, was another one. PREVENT is the latest version, and it has several advantages over those earlier types of risk predictors. For one thing, it predicts risk at younger ages as well. It goes down to age 30. It predicts risk over a longer duration of time, so over 30, 10 or 30 years. It eliminates the use of race as an item to put into the calculator and substitutes for that socioeconomic status, so it's not a race base, but a measure of social disadvantage. And it also includes kidney elements, kidney measures. It includes renal function, for example, that weren't included in prior measures, and it can also be used to predict heart failure, which was not part of the original calculators. Another major advantage of the PREVENT study is that it was based on real-world data from about three million patients, many, many more than the 50,000 or so that the earlier risk calculators were based on. So, it has a much more robust data set and therefore allows a bit more precision in the ability to predict future risk of events. And typically, primary care doctors would enter their patient's data, calculate a risk, and then based on the results of the risk calculator, they can make recommendations about what type of medications a person should take or what other strategies they could use to reduce their risk. And so that's the role that PREVENT plays, is really being focused more for the clinician than the patient. Dr Grouse: Really great tool for us to be aware of. You earlier alluded to the fact that neurologists are in the situation where we sometimes are helping patients with this primary prevention. But you also make a case for why it's in the patient's best interest for us to be involved in, in these conversations when we can, when we have the opportunity. Can you tell us more about that? Dr Elkind: Shared decision-making is really important because we know that people aren't going to lead the healthiest possible lives if they're not invested in their care. And so, a doctor telling somebody what to do if the patient doesn't want to do it is gonna have limited benefit.So we emphasize the importance of shared decision-making as much as possible. And I think that where this comes up a lot is actually in the situation of, for example, atrial fibrillation, where patients will often be put on a blood thinner. And many people are fearful of blood thinners. They worry about the risk of bleeding. Maybe they know a relative who's had a bleeding complication from a blood thinner, and so they may be disinclined to try it. And so, it's really important to have these discussions about the risks and the benefits of medication and engage the patient in thinking about this. And there are even tools and visual aids that people can look to to help explain some of these complicated concepts to patients. So, these are the kinds of things that reflect implementation science as a way to improve adherence. We know what works in a clinical trial setting often, but the challenge is translating that into the real world and getting our patients to use the medications that we believe scientifically have been shown to be of benefit. I've actually been surprised sometimes at conversations I've had with people, in some cases, healthcare professionals who resist going on blood thinners because of their fear of the complications. And I feel like the evidence is there. Why don't they believe me? And that's why it's really important to have the conversation. Even our peers and colleagues can sometimes question the evidence, and it's important for us to be aware of that. Dr Grouse: Absolutely. I think that sounds very reasonable to me, and hopefully these tools will help us with making some of these decisions with our patients. Now, turning our attention a little bit to secondary prevention. So, you know, someone's already had a stroke or a TIA, sort of thinking about what we can do to optimize their risk factors for further strokes. You know, I think there has been some changes that have happened, I think, in the last few years that might be affecting some of the decisions we're making and some of the advice we're giving our patients. I wanted to talk a little bit about GLP-1 receptor agonist medications. Is the data there to support use of this either in secondary prevention or even in primary prevention in the case of stroke? Dr Elkind: There is evidence that supports the use of GLP-1s for stroke prevention. We need more data, though. We need trials that focus only on patients with stroke, for example, there have been studies in patients with cardiovascular disease broadly that include stroke patients. But if you look at the subcategory just of stroke patients alone, the data in that subgroup alone don't always show a benefit. And so, we need more data that's focused on stroke patients alone. So, I think the data are continuing to emerge, but we need more still. Dr Grouse: Is there any development in the thought about whether we should be putting patients on antiplatelet therapies for incidental, incidentally identified strokes? For instance, if you got an MRI for migraine or for other reasons and you found one, no history of any stroke-like symptoms. Should we be putting these patients on aspirin or any other types of therapies? Dr Elkind: That's a really great question. And again, it's an area where there's some controversy and really, there's really no definitive data that would support using antiplatelet therapy in people with incidentally discovered infarcts or what we call, you know, whispering strokes or silent strokes. Many stroke neurologists will use antiplatelet agents. This is one of those areas where it's so important to identify the risk factors. As we were saying before, patients who have other neurological disorders like migraine or epilepsy may turn out to have cardiovascular risk factors like diabetes and high blood pressure. That's why it's so important for neurologists to be able to treat those patients or refer them to specialists who can. Patients who have incidentally discovered lesions similarly are a group where we should be looking for risk factors. So, I don't think of it only in terms of do we put them on an antiplatelet or not, but really more holistically, can we identify their other risk factors and address those? Should the patient's information be entered into a risk calculator like PREVENT, for example, so that we can come up with a more global or holistic measure of their cardiovascular risk and address that as appropriate? Because if they are at risk for stroke, they're also at risk for cardiac events, including heart attack, heart failure, sudden cardiac arrest, and so forth. So, I think of it as a, as a great kind of teachable moment or an opportunity to catch somebody and bring them into the healthcare system more broadly and address those other potential risk factors. Dr Grouse: Speaking of, of risk factors that we often like to think about and work up when possible, in cases where it seems certainly possible the patient had an embolic stroke, but perhaps we've done a few weeks or four weeks of cardiac monitoring, have not found any evidence of atrial fibrillation. What's new and what's the current recommendations for doing further monitoring when there's high suspicion for cardioembolic stroke? Dr Elkind: This is a really active area of investigation, and guidelines suggest that we should do some cardiac monitoring for atrial fibrillation after an unexplained stroke, but it's not clear how much we should do. Studies generally show that the longer you follow somebody on a cardiac monitor after stroke, the more likely you are to detect atrial fibrillation. It could be as high as thirty percent after a few years. And that's great. And if you detect atrial fibrillation, people usually end up being recommended for a blood thinner. But how extensively we should monitor remains unknown. And I think a lot of the investigation recently has been around the question of, are there other ways to get that information rather than waiting six months or a year for the person to develop atrial fibrillation?It's a little bit funny logically to think a person has a stroke today, a year later you discover atrial fibrillation on the monitor, and you say, "Oh, now I know what caused your stroke a year ago." Right? The temporality, the causality perhaps is off in that case. And so, wouldn't it be better if we could tell what somebody's risk of having another cardioembolic stroke is, or the likelihood that they have atrial fibrillation is at the time that you first see them for the stroke, you know, in the hospital, for example. And so, there's some really new technologies that have evolved like AI or artificial intelligence interpretation of EKGs that can give a really good indication of which people are gonna go on to develop atrial fibrillation. And so, I think we need some more trials in that area to demonstrate that we can detect the risk of AFib and treat that even before it appears on one of those delayed monitors. That's an area that I think is very exciting right now. There's also a further question with regard to how to treat these patients, which is that sometimes atrial fibrillation is a consequence of the stroke itself. So, we can think about what people call known AF, meaning atrial fibrillation that's known about before the stroke even occurs, versus AF that's detected after a stroke, or AF-DAS, people will say. Those may have very different implications for the risk of recurrence and what the person's cardiovascular status is. So, I think what we've learned over the last few years is that atrial fibrillation, it used to be like the slam dunk for a stroke neurologist. It was the easy thing. You know, you had a stroke, you have AFib, you should be on a blood thinner. Now we know that there's lots of different kinds of AFib. There's AFib before stroke, there's AFib after stroke, there's burden of atrial fibrillation. So, some people may have 30 seconds of AFib, some people may have several hours, some people may be in it continuously. It comes and goes, and that can make it challenging to manage. So, we have a lot more work to do to understand this problem better. Dr Grouse: That also gets me into some other interesting areas that I think there's still some question, you know, how aggressive should you be? How often is it a case of is this correlated or is this causative? For instance, when a patent foramen ovale is, is discovered in patients with cryptogenic stroke. Are there any tools or new developments to help us understand whether these PFOs should be closed in these cases? Dr Elkind: PFO and stroke is a great story that's been going on for decades. And again, we've made tremendous progress in the last several years. So, it's true that about 20% or so of people have a PFO, and because of that, it can be really hard to say with any certainty whether an individual patient sitting in front of you, that the PFO was the cause of their stroke. Rarely we can have a really high degree of certainty. You know, if somebody has, uh, a DVT, for example, and shortly after that maybe they have pulmonary embolism and then a stroke, and we can say, "Oh, clearly this was a paradoxical embolism," went to the lungs and then some crossed over and went to the brain. That happens really infrequently. Most of the time you're faced with a patient who has a PFO and a stroke, and they may have some other risk factors. There are some tools that we can use to help figure out the likelihood that a PFO is related to a stroke. One of those is called the ROPE score or the risk of paradoxical embolism score that was developed by David Thaler and, uh, David Kent from Tufts and a group of other investigators as well. That score allows one to say what the likelihood is that the PFO was causative of the stroke, and it's based on a person's risk factors such that the younger you are, the more likely it is the PFO caused the stroke. And the absence of risk factors make it more likely that the PFO caused the stroke. So, the higher your ROPE score indicating the fewer other reasons you have a stroke, the more likely the PFO is to be causative. So that can be helpful in identifying patients who may have had a stroke due to their PFO. There are other features that are identified in something called the PASCAL score, which is a way of assessing the degree of shunting and whether or not there's an atrial septal aneurysm that can be used as additional factors that lead to the likelihood that a PFO was causative rather than just incidental. So, by putting this kind of information together, we can kind of do precision neurology or precision prevention by identifying which patients with a PFO are really the ones we need to worry about and do procedures like closure. Dr Grouse: I look forward to hearing more and learning more as more advances are made in these areas. Dr Elkind: Thank you. Dr Grouse: And thank you so much for joining us today to talk about your article. Dr Elkind: Oh, I appreciate it. Thank you for giving me the opportunity. I really enjoyed it. Dr Grouse: Again, today I've been interviewing Dr. Mitchell Elkind about his article on stroke prevention. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.
rWotD Episode 3331: Andrea Olmstead Welcome to random Wiki of the Day, your journey through Wikipedia's vast and varied content, one random article at a time.The random article for Wednesday, 17 June 2026, is Andrea Olmstead.Andrea Olmstead (born September 5, 1948) is an American musicologist and historian.Reared in Grand Forks, North Dakota, Olmstead studied violin with Burton Kaplan in New York and with Lea Foli at the Aspen Music Festival; she was a member of the New York Youth Symphony and the National Orchestral Association. She then embarked upon the study of musicology; her instructors included Gustave Reese, George Perle, H. Wiley Hitchcock, Barry S. Brook, James Haar, Brian Fennelly, and Jan LaRue. Her teaching career took her to The Juilliard School, from 1972 until 1980; the Aspen Music School, from 1973 to 1976; the Boston Conservatory, from 1981 to 2004; the New England Conservatory, from 2006 to 2018; and the University of Massachusetts, Amherst, from 2009 until 2010. The author of numerous books, she has also produced articles in Journal of Musicology, Perspectives of New Music, The Journal of the Arnold Schoenberg Institute, Tempo, Musical America, and The Musical Quarterly, reviews, program notes, and liner notes; she has also given pre-concert lectures and produced CDs. From 2005 until 2007 she was the Christopher Hogwood Research Fellow of the Handel and Haydn Society Orchestra and Chorus. Olmstead is especially well-regarded for her work on the music of Roger Sessions and for her history of The Juilliard School. Vincent Persichetti; Grazioso, Grit, and Gold, was awarded the 2019 ASCAP-Deems Taylor Award for Outstanding Musical Biography. Other honors have included three awards from the National Endowment for the Humanities, and she has spent time as a visiting scholar at the American Academy in Rome and as a fellow of the Virginia Center for the Creative Arts. Olmstead is married to composer Larry Thomas Bell, for whom she adapted the play Holy Ghosts by Romulus Linney into an opera libretto; in 2009 she produced its premiere in Boston.Olmstead's papers are held by the New York Public Library, to which she donated them in 2013.This recording reflects the Wikipedia text as of 00:40 UTC on Wednesday, 17 June 2026.For the full current version of the article, see Andrea Olmstead on Wikipedia.This podcast uses content from Wikipedia under the Creative Commons Attribution-ShareAlike License.Visit our archives at wikioftheday.com and subscribe to stay updated on new episodes.Follow us on Bluesky at @wikioftheday.com.Also check out Curmudgeon's Corner, a current events podcast.Until next time, I'm neural Kajal.
If you've ever gotten the A+, the promotion, the passed board exam... and felt good for maybe two days before sprinting toward the next thing, this episode is for you. This week I'm joined by Dr. Shivana Naidoo, a child and adult psychiatrist I met at a women physicians conference, where her talk hit me so squarely in the heart that I tracked her down afterward and asked her to come on the show. We get into the chase, that hamster wheel so many smart, overachieving women are running without even noticing, because the running has become who we think we are. Shivana shares the moment she realized the system was never going to hand her the credit she was waiting for, and the small, slightly rebellious thing she did about it. About Dr. Shivana Naidoo: Dr. Shivana Naidoo, MD is a double board certified Adult Psychiatrist, and Child-Adolescent Psychiatrist, who aims to help her patients and community to know better, do better and feel better. She is the creator/host of the podcast Thinking It Through with Dr. Naidoo- Child Psychiatrist and the founder of DoBetterMD her telehealth private practice. She greatly enjoys working with female professionals and overachieving teens in her practice. She is currently an Attending at the Bradley REACH Virtual Partial Psychiatric Hospital Program, and is a Clinical Assistant Professor of Psychiatry and Human Behavior at the Warren Alpert Medical School of Brown University. She also serves as the Lead Psychiatrist for the Pediatric Mental Health Care Access Program, an initiative to support primary care providers to address the current mental health care crisis in the state of Arizona. In 2025, she was inducted as a Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry. In February 2026, she was chosen as a speaker for the Women Physician Wellness Conference Climb in Cayman Islands. She is a proud New Yorker who has relocated to Chandler, Arizona. When she is not working as a physician, speaker or podcaster, she enjoys reading stories to her 2 boys, writing songs, and playing guitar. Resources: Get full show notes and more information here: https://www.burnstressloseweight.com/223 Learn more about the Restore Retreat: https://burnstressloseweight.com/retreat Dr. Shivana Naidoo podcast: https://www.dobettermd.com/podcast Connect with Dr. Shivana Naidoo on Instagram: https://www.instagram.com/dr.shivana.naidoo/
In this episode of our pediatric neurology series, host Paul Wirkus, MD, FAAP and guest Josh Bonkowsky, MD explore the rapidly evolving field of gene therapy and its potential to transform the care of children with neurologic disorders. Our guest explains the science behind gene therapy, including how these treatments work to target the underlying causes of genetic disease.The conversation also examines emerging approaches to gene editing and the exciting possibilities these technologies hold for the future of pediatric medicine. Alongside the promise of these innovations, we discuss the challenges, ethical considerations, and unanswered questions that accompany this new era of precision medicine.Throughout the episode, our guest emphasizes the importance of helping patients and families understand complex treatment options so they can make informed decisions as the landscape of genetic diagnosis and therapy continues to evolve.Have a question? Email questions@vcurb.com. Listener questions will be answered in episode four. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP. Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Send us Fan MailAbout Dr. Jeff BanasDr. Jeff Banas graduated from Roosevelt University in 2010, completing the Honors Program to earn his Bachelor of Science in Biology with a minor in Chemistry. He earned his Doctor of Optometry degree from the Illinois College of Optometry, the nation's first and oldest optometric program. His clinical training included rotations at Ochsner Medical Center in New Orleans, the Illinois Eye and Ear Infirmary in Chicago, and the Zablocki VA Medical Center in Milwaukee.Dr. Banas is a Fellow of the American Academy of Optometry (FAAO) and a member of the Optometric Glaucoma Society. He also holds membership in the American Optometric Association, Wisconsin Optometric Association, and Milwaukee Optometric Society, and is certified by the National Board of Examiners in Optometry.His clinical practice focuses on ocular disease management, with particular expertise in glaucoma, diabetic eye disease, dry eye, age-related macular degeneration, cataracts, and refractive conditions. Dr. Banas also provides post-surgical care and is proud to be a part of an ophthalmology team recognized for its adoption of advanced technologies and innovative treatment approaches.
Episode Summary:In this engaging and informative episode of the Pain Matters Podcast, hosts Sudheer Potru, DO, FASA, FASAM, and Co-Host Zafeer Baber, MD, sit down with renowned chronic pain advocate, Tom Norris. With a four-decade-long journey through the challenges of chronic pain, Tom shares his invaluable insights regarding the newly drafted Acute Low Back Pain Guideline** (drafted by the Pacific Northwest Evidence-based Practice Center at Oregon Health & Science University (OHSU EPC) and the American Academy of Pain Medicine), recently submitted to Pain Medicine Journal and currently under review. His unique perspective underscores the critical need for clear communication and collaboration between clinicians and patients, especially in the context of guideline development and healthcare delivery. Throughout the discussion, the trio delves into practical strategies for managing acute and chronic pain, emphasizing the importance of patient-centered communication, the role of alternative therapies, and the power of support groups. Tom candidly discusses his military background and how it has shaped his ability to advocate effectively for himself and others within the medical community. The episode also explores the significance of understanding non-pharmacologic pain management techniques, such as virtual reality, acupuncture, and Tai Chi, and the need for greater awareness and education on these options. Anchored by Tom's wealth of experience and wisdom, this episode serves as a robust resource for both healthcare providers and patients seeking to enhance their pain management approaches. Key Takeaways:Patient-Centered Communication: Building trust and understanding between clinicians and patients is crucial in effectively managing pain and implementing guidelines. Integrative and Alternative Therapies: Non-drug approaches like acupuncture, virtual reality, and Tai Chi can be beneficial in managing pain, but public awareness about these methods is limited. Support Groups' Role: Connecting with others facing similar pain challenges can provide essential support and insights, offering solace and practical advice. Empowering Patients: Patients should proactively educate themselves, prepare questions for their providers, and seek various treatment avenues to optimize their care. Guideline Development Insight: Having patients involved in the creation of medical guidelines ensures that the recommendations are practical and resonate with those they are designed to help. *Views expressed by our guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine. **The Pacific Northwest Evidence-based Practice Center (PNW-EPC) at Oregon Health & Science University (OHSU) is partnered with AAPM for the development of an evidence-based clinical practice guideline on the assessment and management of acute low back pain (ALBP). This project was financially supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award [FAIN] totaling $1,999,980.00, with 100 percent funded by FDA/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, FDA, HHS, or the U.S. Government. The funders had no decision-making role in designing and conducting systematic review, data collection, analysis, and interpretation of the data or approval privilege on the recommendation and good practice statements. As requested, the FDA provided nonbinding feedback and technical support to the guideline panel and methodological team. A methodologically rigorous systematic review on assessment and management of ALBP was conducted by the PNW-EPC to provide evidence for guideline development. An independent, multidisciplinary guideline development used evidence from the systematic review to formulation evidence-based clinical recommendations to the guide assessment and management of ALBP.
Today it is my immense pleasure and honor to welcome Amitav Ghosh to Speaking Out of Place to talk about his new novel, Ghost Eye. The novel is about reincarnation, but also a lot more. In our conversation we talk about the need to address the terrible set of environmental and other crises we face, and the seeming foreclosure of the imagination by the obsession with technology and the future it offers to us. Instead, we look to how we can fashion beginnings out of endings, aided by a renewed sense of wonder, curiosity, and awe. We turn to the body, to the haptic, and perhaps most important, to food as more than simply nourishment. In all this, story-telling, the revival of connections between living beings, and a deep sense of other times and places are central.AMITAV GHOSH grew up in India, Bangladesh and Sri Lanka and has a Ph.D. in Social Anthropology from the University of Oxford. He is the author of four books of non-fiction, two collections of essays and nine novels. His books have won many prizes and he has received eight honorary degrees, six lifetime achievement awards and four honorary fellowships. His work has been translated into more than thirty languages and he has served on the Jury of the Locarno and Venice film festivals. In 2018 he became the first English-language writer to receive India's highest literary honor, the Jnanpith Award. In 2019, Foreign Policy magazine named him one of the most important global thinkers of the preceding decade. In 2024 he was awarded the Erasmus Prize and was elected to the American Academy of Arts and Sciences. In 2025 he was awarded the Pak Kyongni Prize by South Korea's Toji Foundation, and in 2026 he was given a Fellowship by the Guggenheim Foundation. He is married to the writer Deborah Baker and lives in Brooklyn, New York.
If orthopaedic surgeons stop showing up, who decides what our profession becomes? We sit down with Dr. Fred Azar, past president of the American Academy of Orthopaedic Surgeons, a longtime leader and current Department Chair at Campbell Clinic Orthopaedics, to talk about the future of organizational involvement in orthopaedic surgery and why it matters more than ever as healthcare grows more complex.We get practical about the pressures surgeons feel right now: hospital employment, limited reimbursement for memberships, shrinking time, and the reality that many clinicians no longer want to “fly to learn.” Dr. Azar argues that the winning model is not meeting-based societies but connected knowledge networks where education, mentorship, data science, AI, and shared outcomes move fast and reach surgeons where they live. The standard for engagement changes too: it has to be meaningful, efficient, and clearly tied to impact for patients.If you care about the future of musculoskeletal care, this is a conversation about unity, credibility, and showing up before someone else writes the rules. Subscribe for more, share this with a colleague, and leave a review with your take: what would make organizational involvement worth your time today?
Today's guest is Ambassador Patrick Theros, Strategic Advisor and Non-Resident Senior Fellow at the Gulf International Forum. He served as the U.S. Ambassador to the State of Qatar from 1995-1998, and from 1991-1993, served as the Political Advisor to the Commander-in-Chief of Central Command (CENTCOM). In this episode, Alon and Ambassador Theros discuss the US-Israel-Iran war and the pending peace agreement between the US and Iran, the impacts of the war on the region, and how this conflict has affected the political prospects of Donald Trump and Benjamin Netanyahu. Full bio Ambassador Patrick Nickolas Theros is a Strategic Advisor and Non-Resident Senior Fellow at the Gulf International Forum. He served as the U.S. Ambassador to the State of Qatar from 1995-1998. Prior to his appointment, he served as Deputy Coordinator for Counterterrorism, responsible for the coordination of all U.S. Government counterterrorism activities outside the United States. From 1991-1993, Ambassador Theros served as the Political Advisor to the Commander-in-Chief of Central Command (CENTCOM). Ambassador Theros joined the Foreign Service in 1963, and served in a variety of positions in Washington D.C., Saudi Arabia, Lebanon, Nicaragua and Syria, including charge d'affaires and Deputy Chief of Mission at the U.S. embassies in the United Arab Emirates and Jordan. In 1999, His Highness Sheikh Hamad bin Khalifah Al-Thani awarded Ambassador Theros the Qatar Order of Merit for his efforts in service of the U.S.-Qatar bilateral relationship. His commitment to national service also earned him the President's Meritorious Service Award and the Secretary of Defense Medal for Meritorious Civilian Service (1992). Ambassador Theros has also earned four Superior Honor Awards, the highest awards for distinguished service given by the Foreign Service. After his retirement from the Foreign Service Ambassador Theros assumed the office of President of the U.S.-Qatar Business Council in March 2000 until his retirement in 2017. Ambassador Theros' personal commitment to community and public service earned him the rank of Knight Commander of the Order of the Holy Sepulcher by the Greek Orthodox Patriarch of Jerusalem (1999), as well as the Ellis Island Medal of Freedom (2005). In addition to his duties as President of the U.S.-Qatar Business Council, Ambassador Theros is also active in the following organizations: The Middle East Policy Council, Board of Directors; The Council of Foreign Relations, Member; The Washington Institute of Foreign Affairs, Member; and The American Academy of Diplomacy, Member. Ambassador Theros graduated from Georgetown University's School of Foreign Service in 1963. He has done advanced studies at the American University in Washington, D.C., the Universidad Centroamericana in Nicaragua, the Armed Forces Staff College at Norfolk, Virginia, and the National Defense University in Washington, D.C. He is married to Aspasia (nee Pahigiannis) and has three children. He speaks and reads Spanish, Arabic and Greek professionally.
Dr. Natalia S. Rost from The American Academy of Neurology joined Vineeta on The WCCO Morning News.
Ira Helderman PhD, LPC (Adjunct Professor of Religion, Psychology, and Culture, Vanderbilt University; PhD, Religious Studies, Vanderbilt University, 2016) studies how psychotherapists' definitions of what is and is not religious shape their understandings of caregiving, health, and illness. His first book, Prescribing the Dharma: Psychotherapists, Buddhist Traditions, and Defining Religion (University of North Carolina Press 2019), is the first comprehensive examination of the surprisingly diverse ways that psychotherapists have approached Buddhist traditions. Helderman publishes in peer-reviewed journals such as The Journal of the American Academy of Religion and, committed to public scholarship, writes regularly for popular publications such as Psychology Today, Religion Dispatches, and Tricycle: The Buddhist Review. Dr. Helderman is also a practicing psychotherapist and clinical supervisor who has worked in the mental health field for over 20 years in a variety of clinical settings from in-patient addiction treatment centers and psychiatric hospitals to his current private practice. Helderman is currently studying the widespread psychotherapeutic use of Buddhist meditation. Though meditation is often described by patients as a way of easing spiritual yearning, it can also generate "adverse effects" like agitation, traumatic memories, and hallucinations. Dr. Helderman will examine how psychotherapists have conducted a "differential diagnosis" of such cases—distinguishing spiritual experience from psychopathology—and showing that how we define what is and is not "religious" shapes the fields of mental health, psychology, and religious studies. Visit Sacred Writes: https://www.sacred-writes.org/templeton-working-group Visit Dr. Ira Helderman: https://irahelderman.com
Podcast summary of articles from the April 2026 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine. Topics include bystander CPR, Sepsis, Regional Anesthesia under POCUS, Toxicology, Diabetes, and HIV screening. Guest speaker is Dr. Kinda Sweidan.
ResearchWorks is heading to AACPDM 2026 in Philadelphia this year!We can't wait to see you there - it's a special 80th Annual Meeting for the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM).Join with us as we speak with Dr Kristie Bjornson - live from EACD 2026 in Galway Ireland, the final episode that we recorded on our European tour! A preview of what to expect from this year's annual congress and a look at the host city, Philadelphia!Register here:https://www.aacpdm.org/events/2026/registration
In this week's conversation between Dr. James Emery White and co-host Alexis Drye, they discuss a recent lawsuit against the fast-food chain Chick-fil-A. Lauren Weber wrote an article in The Wall Street Journal that prompted today's conversation titled, “Sundays Are Sacred at Chick-fil-A. The U.S. Says a Worker's Saturday Sabbath Is, Too.” The restaurant is known for giving employees Sundays off to observe the Christian Sabbath, but found themselves being sued for denying an employee's request to have Saturdays off. Her denomination, the United Church of God, observes the Sabbath on Saturdays. So which day should the church observe? And what, really, defines a Sabbath? Episode Links The practice of observing a Sabbath day is something that has been declining among people who would consider themselves Christ followers. However, God felt that this was such an important part of our lives that the call to observe the Sabbath is one of the Ten Commandments. Dr. White delivered a series at Mecklenburg Community Church simply titled, “Ten,” which explored the biblical and cultural significance of each of the Ten Commandments. You can find that series at Church & Culture HERE. As Dr. White explained, as a society we've so overly cluttered our lives that it's hard for so may of us to even wrap our heads around taking a day to rest and renew. He referenced an old article from Newsweek featuring Neil Rudenstine, the (then) president of Harvard University, who once faced extreme exhaustion. It was titled “Breaking Point,” and you can read that article HERE. He also discussed a 2025 Forbes article about how an increasing number of employees are taking sabbaticals, something that's really helping with career longevity. You can read the article titled “Why More Professionals Are Taking Sabbaticals—And How It's Transforming Work And Well-Being” HERE. Dr. White referenced a recent announcement from the American Academy of Pediatrics updating their policy statement on the need for children to return to more play. He used this as inspiration for a recent Church & Culture blog titled “We All Need Recess,” which you can read HERE. Finally, Dr. White discussed the importance of the church needing to teach on topics related to rest and the Sabbath. In addition to the series “Ten,” we'd encourage you to check out another recent series that he gave called “Quieting Your Life.” This series explored the call to quiet ourselves, how we need to be quiet and seek quiet, and the significance of a daily quiet time. You can find that series on Church & Culture HERE. For those of you who are new to Church & Culture, we'd love to invite you to subscribe (for free of course) to the twice-weekly Church & Culture blog and check out the Daily Headline News - a collection of headlines from around the globe each weekday. We'd also love to hear from you if there is a topic that you'd like to see discussed on the Church & Culture Podcast in an upcoming episode. You can find the form to submit your questions at the bottom of the podcast page HERE.
Rätsel des Unbewußten. Ein Podcast zu Psychoanalyse und Psychotherapie
Was ist Limerenz? Wie unterscheidet sie sich von "normaler" Verliebtheit? In dieser Folge sprechen wir über obsessive Verliebtheit, Projektionen, Sehnsucht und die Frage, warum gerade das Unerreichbare eine so große Macht über uns gewinnen kann. - Vertiefungsfolge "Limerenz": https://www.patreon.com/raetseldesubw/posts/limerenz-liebe-160694285/edit Unser Hörbuch "Jetzt bin ich schon wie meine Eltern": https://www.patreon.com/collection/2029837 (Kollektion kaufen = Einmalkauf Hörbuch) Ausschnitt und Infos: https://www.patreon.com/posts/151955086?collection=2029837 Literaturempfehlung zur Folge: - König, Fabian (2023). Liebe und Limerenz. Die Erfahrung des Verliebt Seins. Vortrag beim bvvp Hessen. - Sperling, Michael (1988): Phenomenology and Developmental Origins of Desperate Love. In: Psychoanalytic Contemporary Thought, 11(4), S. 741–761. - Chessick, Richard D. (1992): On Falling in Love and Creativity. In: Journal of the American Academy of Psychoanalysis, 20(3), S. 347–373. - Tennov, D. (1998). Love and limerence: The experience of being in love. Scarborough House. - Verhulst, Johan (1984): Limerence. Notes on the Nature and Function of Passionate Love. In: Psychoanalytic Contemporary Thought, 7(1), S. 115–138. Skript zur Folge: https://www.patreon.com/raetseldesubw/posts/tiefseeltauchen-160703122 Hilfsmöglichkeiten bei psychischen Krisen: https://www.stiftung-gesundheitswissen.de/gesundes-leben/psyche-wohlbefinden/hilfe-bei-psychischen-problemen-diese-stellen-koennen-sie-sich In psychischen Krisen können auch Hausarzt/ärztin, Psychiater/in und Psychotherapeut/innen Ansprechpartner sein. In Notfällen kann man sich zudem an eine psychiatrische Klinik wenden. Rätsel-des-Unbewussten-Abo als Geschenk: https://www.patreon.com/raetseldesubw/gift Beschreibung der Level-Inhalte: https://www.patreon.com/c/raetseldesubw/membership Wenn ihr alle bisher erschienenen handgebundenen Hefte bekommen wollt (12 Hefte) => Jahresabo auf dem Level "Liebhaber" - Vertiefungsfolge "Beendigung von Therapien" auf Patreon: https://www.patreon.com/posts/127931630 - Folge zu Glenn Gabbard und den "liebeskranken" Analytiker: https://www.patreon.com/posts/121877727?collection=148939 Skript zu dieser Folge: https://www.patreon.com/posts/145065724 Kontakt: lives@psy-cast.org Erziehungskonzepte psychoanalytisch betrachtet (5 Teile): https://www.patreon.com/collection/148943 Digitaler Lesekreis zum Thema "Wie die Digitalisierung unsere psychische Struktur verändert" (1. Folge ist frei zugänglich): https://www.patreon.com/posts/lesekreis-werner-94838102 - Bestellung unseres Buches über genialokal: https://www.genialokal.de/Produkt/Cecile-Loetz-Jakob-Mueller/Mein-groesstes-Raetsel-bin-ich-selbst_lid_50275662.html und überall, wo es Bücher gibt. Auch als Hörbuch! - Link zu unserer Website: www.psy-cast.de - **Wir freuen uns auch über eine Förderung unseres Projekts via Paypal**: https://www.paypal.com/donate/?hosted_button_id=VLYYKR3UXK4VE&source=url - Anmeldung zum Newsletter: https://dashboard.mailerlite.com/forms/394929/87999492964484369/share Musik: Evergreen, Kintsugi (licenced via premiumbeat.com)
Ronald Hsu, DDS, of Storybook Dentistry in Camas and Dr. Megan Miller of Expedition Pediatric Dentistry offer guidance on credentials, communication style, and why the American Academy of Pediatric Dentistry recommends a child's first dental visit by age one. https://www.clarkcountytoday.com/youth/how-to-choose-a-pediatric-dental-provider/ #PediatricDentistry #ChildrensDentalHealth #DeltaDentalWA #OralHealth #YouthHealth #ClarkCounty #WashingtonState #DentalCare #ParentingTips #DentalHome
Full show notes: https://bengreenfieldlife.com/dralbert In this episode, Dr. Pradeep Albert breaks down the science behind HarmonIQ, formerly Hapbee, a wearable wellness company using frequency-based technology to help you access specific physiological states on demand, from deeper sleep and sharper focus to stress reduction and addiction support, all without ingesting anything. This episode also marks the official launch of HarmonIQ and its new pet-focused line Hapbee Pets. You'll discover why quality sleep without pills is the non-negotiable foundation on which every advanced longevity therapy sits, what Dezawa MuseCells are doing to cartilage and bone in professional athletes who would otherwise be facing surgery, and where CAR T-cell therapy is headed over the next decade. You'll also gain insights into peptide stacks including LL-37, ipamorelin, tessamorelin, MOTS-c, PT-141, cerebrolysin, and GHK-Cu, and what the recent FDA reclassification of 14 peptides back to Category 1 means for anyone currently using or considering them. Dr. Pradeep Albert, MD, DABR, is a board-certified musculoskeletal radiologist, author, and internationally recognized thought leader in regenerative medicine and longevity science. Over three decades, he has performed thousands of regenerative procedures, treated professional athletes across the NFL, MLB, NBA, and NHL, published over 50 peer-reviewed articles, and shaped peptide and stem cell legislation across multiple countries including advising heads of state on healthcare policy. He is the CEO of Vesalius Longevity Labs, founder of the American Academy of Peptide Medicine, and creator of RadSherpa, an AI-powered diagnostic platform now deployed in 89 countries. Save $50 on your HarmonIQ Limitless Neckband and Hapbee Pets Pad (discount auto-applied). Episode Sponsors Fatty15: Fatty15 is on a mission to optimize your C15:0 levels and help you live healthier, longer. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/BEN and using code BEN at checkout. Hiya: Give your kids the full-body nourishment they need to grow into healthy adults. I’ve secured a special deal with Hiya on their best-selling children's vitamin—get 50% off your first order today! To claim this deal, you must go to hiyahealth.com/BEN (it is not available on their regular website). Young Goose: To experience the transformative power of Young Goose's cutting-edge skincare products, visit younggoose.com and use code BGF10 at checkout to enjoy a 10% discount on your order. Quantum Upgrade: Recent research has revealed that the Quantum Upgrade was able to increase ATP production by a jaw-dropping 20–25% in human cells. Unlock a 15-day free trial with the code BEN15 at quantumupgrade.io. Pendulum: Metabolic Daily is a powerful multi-strain probiotic that improves your metabolism, reduces sugar cravings, breaks down carbs more efficiently, and sustains your energy levels. You’ll receive 20% off your first month of any Pendulum probiotic with code BEN at PendulumLife.com.See omnystudio.com/listener for privacy information.
This episode of the Brain & Life Podcast was recorded live at the American Academy of Neurology's Annual Meeting. Co-hosts Dr. Daniel Correa and Dr. Katy Peters were joined by Jen Pollack from Alzheimer's Association, Rich Brennan from ALS Association, and Julienne Verdi from Alliance for Headache Disorders Advocacy to discuss how advocacy and sharing stories makes a difference. Tune in to hear these field experts share the positive effects of collaboration and advocacy! Additional Resources Become a Brain Health Advocate The Why Behind Your Weakness- ALS Association ASAP Act- Alzheimer's Association HEADACHE Act- Alliance for Headache Disorders Advocacy We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? · Record a voicemail at 612-928-6206 · Email us at BLpodcast@brainandlife.org Social Media Guests: ALS Association @als; Alzheimer's Association @alzassociation; Alliance for Headache Disorders Advocacy @allianceforheadacheadvocacy Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD
Why are more people becoming afraid of vaccines than the diseases vaccines were created to prevent? The answer is not simply a lack of information. In many ways, vaccines have become victims of their own success.For decades, widespread vaccination helped push diseases like measles, polio, pertussis, and smallpox out of everyday life. Many of us no longer live with the visible fear of these infections, their complications, or the way they can destabilize families, communities, and healthcare systems.But when the disease feels distant, the vaccine can start to feel like the bigger threat.That shift is now changing public health.Rather than assuming vaccine hesitancy is only about ignorance or defiance, we need to look more carefully at:• why people can become more suspicious of vaccines when they no longer see the diseases vaccines helped control• How misinformation, fear, personal experience, politics, history, and social media can shape health decisions• Why highly educated people can still be vulnerable to vaccine misinformation• how confusing a side effect, adverse event, or normal immune response with a true allergy can create long-term fear• Why egg allergy is no longer the vaccine barrier many people still believe it is• And how declining vaccination rates can allow diseases like measles and pertussis to reemergeVaccine education has to move beyond simply telling people what to do. We need clearer, more compassionate conversations that acknowledge fear while helping people separate facts from fiction.In this upcoming episode, I'm joined by Dr. Joyce Yu, associate professor of pediatrics and director of the Food Allergy Program at Columbia University Irving Medical Center.Together, we explore:What is driving the rise of vaccine hesitancyWhy vaccine-preventable diseases can return when communities let their guard downHow allergists help patients understand whether a vaccine reaction is truly an allergyAnd why rebuilding trust requires listening, clarity, and evidence-based conversationIf you or someone you love has ever felt uncertain, afraid, or confused about vaccines, allergic reactions, side effects, or conflicting health information, this conversation offers a grounded look at how fear spreads, how misinformation takes hold, and why protecting public health depends on rebuilding trust.Guest BioDr. Joyce Yu is an associate professor of pediatrics and director of the Food Allergy Program at Columbia University Irving Medical Center. She is an allergy and immunology specialist with clinical and scientific expertise in food allergy, immunology, vaccine-related concerns, and immune system function. Dr. Yu received her medical education at the Icahn School of Medicine at Mount Sinai, completed her residency at Northwestern/Lurie Children's Hospital, and completed her fellowship in Allergy and Immunology at Mount Sinai. Her postdoctoral work focused on toll-like receptor signaling and memory B cell development, mechanisms that are closely connected to how the immune system develops lasting protection. She is a fellow of both the American College of Allergy, Asthma & Immunology and the American Academy of Allergy, Asthma & Immunology. She is also a former president of the New York Allergy and Asthma Society and has held leadership roles within the Clinical Immunology Society. Connect with Dr. Yu on LinkedIn.About Your HostHosted by Dr. Deepa Grandon, MD, MBA, a triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidence-based lifestyle medicine.Disclaimer TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced.Work With Me Learn More About My Soon-to-Launch Telemedicine PlatformExciting news. My virtual medical platform is launching soon! If you're looking for personalized, evidence-based care in allergy, immunology, and lifestyle medicine, stay tuned.Visit drdeepa-tlc.org and click on “Learn More” to join the waitlist and be the first to receive updates about services, membership options, and launch details.Precision care. Personalized guidance. Wherever you are.DevotionalsWant to receive a devotional every week from Dr. Deepa? Devotionals are dedicated to providing you with a moment of reflection, inspiration, and spiritual growth each week, delivered right to your inbox. Visit drdeepa-tlc.org to subscribe for free.Trauma CoursesReady to deepen your understanding of trauma and kick-start your healing journey? Explore a range of online and onsite courses designed to equip you with practical and affordable tools. From counselors, ministry leaders, and educators to couples, parents, and individuals seeking help for themselves, there's a powerful course for everyone. Browse all the courses now to start your journey.
Social determinants of health, including housing, food access, insurance status, and structural inequities, significantly influence stroke prevention, recovery, and long term outcomes. These factors affect biological risk, treatment adherence, and disparities in care, even when traditional clinical measures are addressed. This episode highlights practical strategies for integrating screening, leveraging multidisciplinary teams, and identifying opportunities for advocacy to improve patient outcomes. In this episode, Teshamae Monteith, MD, FAAN, speaks with Nneka L. Ifejika, MD, MPH, author of the article "Social Determinants of Health and Their Impacts on Stroke Prevention and Outcomes" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. Ifejika is an adjunct professor of physical medicine and rehabilitation at UT Southwestern Medical Center in Dallas, Texas, and the chief scientific officer of the Division of Academics at Ochsner Health System in New Orleans, Louisiana. Additional Resources Read the article: Social Determinants of Health and Their Impacts on Stroke Prevention and Outcomes Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Full episode transcript available here Dr Monteith: Two patients have the same stroke, but when they return, they have very different outcomes. We can look into some of their comorbidities, but something we don't spend enough time talking about is the social determinants of health. Stay tuned to this discussion. I promise you, you'll become a better neurologist. Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Monteith: This is Dr. Teshamae Monteith. Today I'm interviewing Dr. Nneka Ifejika about her article on social determinants of health and their impacts on stroke prevention and outcomes. This article appears in the June 2026 Continuum issue on cerebrovascular disease. How are you? Welcome to our podcast. Dr Ifejika: Thanks for having me. I'm doing great. Dr Monteith: Great. So, can you introduce yourself to our audience? Dr Ifejika: Sure. I'm Dr. Nneka Ifejika. I am the Chief Scientific Officer of Ochsner Health System in New Orleans, Louisiana. But I'm also a cerebrovascular rehabilitation doctor. I've been practicing for about nineteen years, and am happy and honored to be a contributor to this Continuum Neurology article. It's a really important topic. Dr Monteith: Great. So, what got you into this field, first of all? Dr Ifejika: Well, I was deciding between PM&R and neurology, and I was putting in both match lists. And I thought about it and I leaned toward PM&R, but stroke still had a grasp on my heart and my mind. And so, after I finished my residency, I joined the UT Houston stroke team, and I did a, thankfully did a two-year fellowship and became cross-trained in stroke as well as physical medicine rehab. So, I am a jack of both trades. Dr Monteith: So, you got your way in a way. Dr Ifejika: I did. Dr Monteith: You know, we have a lot of learners that are listening, so it's always, uh, nice for them to be inspired, I think, by people's career paths. So why don't we talk about the objectives of your article? Dr Ifejika: Sure. So, one of the most important things that we wanted to do was make sure that medical students, residents, faculty, and fellows understood the impact of social determinants of health on stroke recovery and stroke rehabilitation. It's not as simple as you have hypertension, hyperlipidemia, we're going to manage your stroke risk factors. Oh, you had an ischemic stroke. You presented in time for the window. We're going to give you endovascular therapy and then modified Rankin scale at hospital discharge in ninety days. No, no, no. The stroke survivor and their caregivers and their family have a lot more to deal with outside of what we look at during the acute stroke hospitalization and post-acute rehabilitation. Things like, can they afford the medication that we're prescribing? Antiplatelet agents or anticoagulation can be extremely expensive. Do they have housing insecurity? Is there food insecurity? What's going on behind the scenes that we are not addressing that can directly impact the admission rate and the readmission rate after we take care of a stroke survivor? Dr Monteith: I love the article because you took a real deep dive into social determinants of health, what they are, why they matter, and what we can do about them. And so why don't we talk a little bit about the NINDS framework for social determinants of health? I think many of us might not be familiar with the framework per se. Dr Ifejika: So, the framework consists of multiple domains specifically that relate to social determinants of health that were published in Neurology a couple of years ago. So, I do hope that people who are hearing this recording actually read them. There are interpersonal domains, there are classic medical domains, there are indeterminate domains, and there are six total domains. And health domains are the last domain. So, things like when it comes to housing insecurity, food insecurity, that's a domain of social determinants of health. When it comes to chronic racism, when it comes to biases that patients experience, those actually impact outcomes. So, there are six separate indices that we're going to get into in detail and how we address them as clinicians, whether it be at the medical student level, resident level, faculty level, to integrate the social determinants of health in our care plans, because we could be doing a much better job. And I think it'll be really important from the interpersonal perspective when we really relate to our patients and their families that we ask these questions. For example, if we're prescribing someone to have treatment for their diabetes mellitus and ha- and, and be taking insulin, if they have housing insecurity and they're in a homeless shelter, they have to leave the homeless shelter during the day. So, what happens to the insulin that we prescribe? These are variables that we are not considering on a regular basis, but they directly relate to compliance. Dr Monteith: Great. So that was one thing I wanted to bring up. We're very good at measuring blood pressure and trying to determine, uh, the association between stroke outcomes and things that we can measure, glucose, lipids, blood pressure. What is the evidence for social determinants of health and stroke outcome? Dr Ifejika: The evidence is growing, and there have been many publications that have come out that are, are going to be highlighted in this article related to structural determinants of health inequities, like structural racism, as well as disparities related to ethnicity and race. There's geographical disparities. For example, a lot of patients are, are primarily concerned about rural versus urban, whether you have access to different post-acute rehabilitation, whether you have access to secondary stroke prevention because you simply don't have the transportation from a, a rural area to get to a drugstore to get things available to you. Social status. There are actually publication related to socioeconomic status and the concerns when it comes to air pollution. So particulate matter 2.5, we know that that has a direct impact on stroke outcomes and health overall, but we don't really think about it as a structural determinant of health inequity. There's several multiple layers of research that have gone on specifically that have been cited in the literature that relate directly to social determinants of health and how we can address them moving forward. Dr Monteith: And what I found interesting in your article in that you gave at least a few examples where social factors like income, education were controlled for, and maybe in large part it is, but even when you control for some of these very obvious social risk factors, you still have inequities. Dr Ifejika: Absolutely. And I think it was really important to show that we had strong peer review evidence behind this, as it wasn't just something that we were creating or hypothesizing about. There have been studies that have been done over this over decades of time, showing the impacts of social determinants of health on outcomes. But the question and concern that we have is we know this growing body of literature continues to expand. What are we doing about it when it comes to education of the future generations of providers who will be caring for this population? Dr Monteith: Before we get into how, you know, what we're going to do about that, let's just kind of put that link, cause the evidence is there. How does it drive biology? Dr Ifejika: It's a great question. So, for example, particulate matter 2.5 in air pollution has been shown to have an existing impact on hypertension, raising your blood pressure. So that's a direct effect of a social determinant of health related to socioeconomic status because people who live in areas with higher air pollution are... They're not green spaces. They live near highways. Those are areas that unfortunately are also impacted by food deserts. Food deserts, if you're not able to get fresh fruits, vegetables, whole foods, increases your risk of developing diabetes, hyperlipidemia, also increases your sodium intake, again, increasing hypertension. These things are all connected to biological determinants. It's just that we're not asking about them necessarily within the social history when we're taking people into the hospital, but they have direct effects. Dr Monteith: Great. Neurologists tend to be busy and, you know, we're... have all of these things that we're being asked to do and chart and click and all of that stuff. And so how can we more readily integrate screening for social determinants of health and that conversation into the work we do? We recognize it's important. We recognize it's an important risk factor. There's a lot of these determinants. So, what is a good way to do so? And I, I know that in the paper you've, you've given different roles to different team players, so I want you to talk about that too, but just kind of even a regular routine office visit. Walk us through a way we can more easily integrate that kind of conversation. Dr Ifejika: It's an excellent question, and what I've recommended that we do in a standard office visit is utilize the time before the visit to send out screeners. So, for example, usually with an electronic medical record, you can send documents before the visit even starts, where people can check off whether they have any concerns regarding housing, food insecurity. They can check out their location of where they live, whether they live near a highway or not near a highway. It's specifically related to socioeconomic status. We can ask about insurance status, whether they have insurance, insured versus uninsured, but then also types of insurance, whether they have Medicaid insurance versus Medicare insurance. Then even drilling even further, type of Medicare insurance, Medicare Advantage versus traditional Medicare, cause all of those things actually play a role in this. Dr Ifejika: And evaluate these things and don't take time during your office visit. Send these screeners out beforehand. Have them be assimilated by your medical staff. Make sure you're utilizing every resource that you have at your disposal to help streamline things, so by the time the person comes in for the visit, you've primed the pump. You have this information already in your hands at your fingertips cause it was sent out in advance, and you have your medical staff already have an understanding of. If they didn't fill it out electronically, give it to them in the lobby. Make sure they have a handwritten copy in the lobby so that when they come into the office visit, you have the information at your fingertips. Dr Monteith: Are there any particular resources that you recommend for those types of screeners? Dr Ifejika: What I've used in the past, if you have patient-reported outcomes, so the PROMIS instruments, that's a good start. It doesn't get into the details of housing insecurity, food insecurity, but it's a good start to help prime questions and to start the conversation during your office visit. In my clinics, I do a PROMIS 27 on every patient, as well as a PHQ-9 for depression on everyone. And then I collect data longitudinally, and I can always drill down on factors that I noticed that could become a problem moving forward. Dr Monteith: Yeah. And then also in your article, you spoke a bit about this impact from the acute presentation in the hospital to rehab. Dr Ifejika: Yeah. Dr Monteith: So why don't you talk about these different entry points where we can really engage our patients and try and help reduce their burden? Dr Ifejika: Sure. So, healthcare can be quite fragmented, and the stroke patient, stroke survivor, and their family member have no grasp of that. They've had a stroke, and they may be going from the ER to the ICU to the stroke unit to the floor to the rehab unit, and we see it as multiple levels of care, multiple types of providers. They see it as one hospital. And the concern that we have is, at those branch points, things get dropped, and we have the opportunity to pick things up at those branch points. So, during the acute care hospitalization-Primarily, that's the establishment of what has happened, how we're gonna treat it, what are the variables that we can control for right now to address those determinants of health moving forward, and to specifically looking at whether they were taking medications before, whether they could afford medications before, what that looks like at hospital discharge. Is there any duplication of medications? If a person is taking Coreg and you prescribe metoprolol, but they still have the Coreg at home, should we have really prescribed the metoprolol? We're just spending money that they may have concerns when it comes to access to care and the cost of these prescriptions. So, it's the responsibility of the acute care physician to kind of look at that. Those are subtle things that we think are subtle, but they add up quickly for the family when it comes to having one group of medications that's the same class and having to buy another type. When it comes to post-acute rehabilitation, it's really an important time to screen for whether the caregiver can handle what's occurring. So specifically, if the caregiver is already burning out and the average length of stay for a stroke patient is five days and they've come to rehab for two weeks, what's gonna happen in the next two years or the next four years? So, during the post-acute rehabilitation phase, it's time to kind of look at that and drill down on those kind of questions. Also, the levels of care, Dr Ifejika: it's really important to look at other levels of rehabilitation, so skilled nursing facilities, making sure people have access to that if they need to, if the caregiver is burned out and they don't have the ability to go straight home. Because acute inpatient rehab, the goal of it afterwards, is to go straight home. It's not to go to another facility. So, you need to have that screener in place when it comes to whether the family can take care of this person, and whether the family can do it in an effective way to prevent them being readmitted. Dr Monteith: Great. I also like that you spoke about kind of the team approach and different roles, both for screening and for intervention, both being very important, especially the intervention. And so why don't you give us a few examples how the team could break up the responsibility and how also for the intervention component that can be done. Dr Ifejika: Sure. So, I broke up the team into several levels. So, the team medically is the medical student, resident, and faculty physician. However, the team also includes the support staff, so your case manager, your social worker, the therapist, physical therapy, occupational therapy, speech therapy, the pastoral services, all these members of the team. You know, sometimes as physicians, we don't read those notes. There's a lot of information in the notes from social work, care coordination, and the therapist. They get down to subtleties cause they're asking questions, for example, "What kind of equipment do you have at home? How many stairs do you have at home? What level of house do you have, one story, two story? If you live in an apartment, do you have an elevator access?" That's important for someone with hemiparesis. When it comes to medications, when it comes to insurance status, when it comes to your ability to have the mechanisms to pay for care as an outpatient, social workers are required to ask these questions cause they have to figure out resources for the patient and their family to help facilitate improved outcomes. So, they have to ask questions regarding these tasks. The concerns are, do we read what they're saying? So, it's really important to interact with them, and if it's not something that you're looking at in the chart, cause we're all so tied to our computers, find where they are in the hospital. Walk by their office and have a chat. Run your list with them, especially for people who you're concerned have vulnerabilities, and make sure that you're setting an example for your medical students with your faculty doing so. If you're looking at it from the medical student, resident, faculty perspective, medical students, listen. This is your opportunity to really contribute to the team as well as learn about social determinants of health and research in their fields. You are the boots on the ground for the medical team. You are the ones who should be priming the pump and asking these questions of the family members. We're sending you into the rooms to do a history and physical. Social determinants of health should be a part of your history and physical, and you should be taking what we're saying in this article and asking these questions and tying it into your resident. Now, the resident is the work person of the hospital. We all know this. Things run through the resident. Things run through the fellow. It's really important that they have this information in a manner that is negotiable. The list keeps getting longer, and a resident doesn't need to be overburdened. It needs to be synthesized in a manner that can help facilitate the resident being able to act as well as communicate any concerns to the faculty. And at the faculty level, we are the voices that can affect change. So, if there's any concerns when it comes to advocacy, research, making sure that people are accessing care in a way that makes sense, particularly when it comes to the ability for us to galvanize change on a national level, that's kind of our job. Dr Monteith: Great, and so let's talk about intervention. What are things that, let's say, the neurologist can do to deal with some of these social factors? Dr Ifejika: From the neurology perspective, I think it's really important to identify missed opportunities and making sure that we address them. For example, the conversations around the ability to have access to care related to insurance versus no insurance. There are many, many ways that neurologists are able to advocate for a person being able to get to Medicare insurance, particularly in the outpatient setting. When we see patients in clinic, it takes two years, them, to qualify for Medicare, two years at a minimum. But there's a gap there that can be filled by us making sure that we document what's happened, contact their providers, facilitate communication with their employers, if they're employees, they can get some short-term disability benefits to help bridge that gap prior to receiving Medicare insurance. It behooves us to do this because if we do not, they fall into the gap and they get readmitted and they're back on service anyway. So, what's important is the outpatient that we really kind of focus on things that we can impact and things like insurance and getting people transitioned from having employer-based insurance versus getting to Medicare is a really important way that we can effect change in a, in a way that's viable and, and replicable. So, in the outpatient setting, neurologists have a wonderful opportunity to effect change in social determinants of health. When it comes to employed persons, who had a stroke transitioning to Medicare, it takes two years to do so. So, in the outpatient clinic, if you have an employed person, make sure that you fill out their short-term disability benefits forms, their long-term disability benefits form. Bridge the gap. Get that information to their employer so they can maintain constant coverage. Because if they do not, if they have to choose between refilling medications and putting food on the table, they're going to choose putting food on the table, and that's going to directly impact their outcomes if they're not taking the medication that we recommend. Dr Monteith: I think that's a great point. I mean, there's a lot that we can do, and in some ways, it may not take that much to document and to be able to ask the questions and to include some of that information into the assessment and plan is really a, a great idea. Dr Ifejika: And you know, if we don't bring these things up and have these conversations, it doesn't get addressed. And that's why I'm very, very thankful that I had the opportunity to do so, cause this is a part of what I do all day. I think that if I wasn't integrating these kind of conversations into my practice, I wouldn't have the ability to share these tips and these abilities to move things forward in a manner that will be constructive for our field overall and for our patients. Dr Monteith: And towards the end of the article, you brought up something I think we don't see in many articles, and that's the role of advocacy and getting involved in health policy. So, can you talk a little bit about that? Dr Ifejika: You know, it's really important to facilitate change when you see that there are things that need to be changed. And the best way to do that is through advocacy at the local or state or federal level. A lot of these variables that we're dealing with can be addressed through legal changes. I'll give you an example. End-stage renal disease, if you have immediate hemodialysis and you have that requirement upon hospital discharge, you qualify for Medicare immediately. Immediately. Before you even leave the hospital. Why wouldn't something be similar for a stroke? Well, the reason why is because there was a level of advocacy that came around end-stage renal disease and a member of Congress's wife had hemodialysis requirements. And so, a law was passed to make sure Medicare covered it immediately after hospital discharge. So, it requires advocacy in some significant ways to get things done, but we have the bandwidth to do this. We take care of a population that has some of the highest rates of preventable disability. That's not going away. We need to make sure that we're effecting change for this group to make sure that they have the best possible outcomes they can experience. Dr Monteith: So, any final messages for our listeners? Dr Ifejika: I look forward to hearing everyone's feedback about our issue. I am thankful for the opportunity to talk about, address, and write about this important topic, and look forward to everyone's feedback. Dr Monteith: Well, thank you so much for being on our podcast. It was a really wonderful summary and we had a very thorough conversation, but you didn't give away too much, so I think they're going to have to read the article. Dr Ifejika: You're going to have to read the article. And we want medical students, residents, fellows, faculty, all of our ancillary staff within the hospitals, please read this article. We really appreciate it. Dr Monteith: Again today, I've been interviewing Dr. Nneka Ifejika about her article on social determinants of health and their impacts on stroke prevention and outcomes. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.
The Power of Functional Medicine: Finding the Root Cause of Chronic Health Problems In this episode of Stay Healthy Knoxville, Dr. John-Mark Chesney sits down with Emily Turner, PA-C, and Randy Martin, PharmD, of Omni Functional Medicine to discuss a different approach to healthcare—one focused on identifying and addressing the root causes of chronic symptoms rather than simply managing them. Together, they explore what functional medicine is, why so many people continue to struggle despite being told their labs are normal, and how factors such as hormones, gut health, stress, metabolism, and inflammation can impact overall health and well-being. Whether you're dealing with fatigue, weight gain, digestive issues, autoimmune disease, chronic pain, or simply aren't feeling your best, this conversation offers valuable insight into how a more personalized approach to healthcare may help uncover missing pieces of the puzzle. In This Episode, You'll Learn: ✅ What functional medicine is and how it differs from traditional healthcare ✅ Why patients can still feel unwell despite "normal" lab results ✅ The importance of looking for root causes instead of just treating symptoms ✅ How hormones, gut health, stress, and metabolism influence overall health ✅ Practical steps you can take to improve your health and energy About Our Guests Emily Turner, PA-C Bachelor's Degree in Dietetics – University of Kentucky Master's in Physician Assistant Studies – Sullivan University Advanced training through The Institute of Functional Medicine Advanced training through The American Academy of Anti-Aging Medicine Randy Martin, PharmD Doctor of Pharmacy – University of Tennessee Co-founder of Omni Functional Medicine Connect with Omni Functional Medicine Instagram: @omnifunctionalmedicine Website: omnifunctionalmedicine.com Enjoying the Podcast? Be sure to subscribe, leave a review, and share this episode with someone who may be searching for answers to ongoing health concerns. Stay healthy, Knoxville!
In this episode of See See by Ceci, N. Katherine Hayles, Distinguished Research Professor at UCLA, James B. Duke Professor Emerita at Duke, Guggenheim Fellow and member of the American Academy of Arts and Sciences, joins us from the rare crossroads at which she has worked for forty years: literature, science, technology and, now, artificial intelligence. Trained as a chemist at Rochester and Caltech before crossing into literary scholarship, she is a foremost authority on the relations between literature and computational media, and the author of How We Became Posthuman (1999) and, most recently, Bacteria to AI: Human Futures with our Nonhuman Symbionts (University of Chicago Press, 2025). In this rich and demanding conversation, Hayles redefines cognition as the interpretation of information in contexts that connect with meaning, a capacity she ascribes to bacteria, plants, fungi, animals and, increasingly, AI. She walks us through her integrated cognitive framework and the SIRAL criteria (sensing, interpreting, responding adaptively, anticipating, learning); through von Uexküll's umwelt, the world each species spins for itself; through cognitive assemblages in which humans, microbes and machines decide together; and through her sharp distinction between actors and agents. As a literary critic, she also turns her gaze on AI-produced literature, on hallucinations as imagination, and on Walter Benjamin's aura in the age of the deep fake. With reflections from neuroscientist John Cryan on the gut microbiome, historian Richard Bourke on the Kantian self, classicist Richard P. Martin on AI and imagination, and choreographer Alexander Whitley on embodiment. This is an episode about the uncoupling of cognition from consciousness, Hayles' most crucial move. About a posthuman in which the human itself is being rewritten. And about the very determined optimism of a thinker who insists that hope is not the reward at the end of the work, but the precondition for it. N. Katherine Hayles is the author of twelve influential books, including the landmark How We Became Posthuman, widely regarded as a seminal foundation for posthumanism, My Mother Was a Computer: Digital Subjects and Literary Texts (2005), Unthought: The Power of the Cognitive Nonconscious (2017), and her latest, Bacteria to AI: Human Futures with our Nonhuman Symbionts (University of Chicago Press, 2025). A member of the American Academy of Arts and Sciences and recipient of fellowships from the Guggenheim Foundation, the National Endowment for the Humanities, and the Rockefeller Foundation, Hayles has transformed our understanding of the digital age.
In Episode 2 of our pediatric neurology series, we explore how advances in diagnostic technology have transformed the field of neurology. Our guests discuss the evolution of neurologic evaluation - from early ultrasound imaging to CT and MRI - and how modern imaging has revolutionized the ability to diagnose and understand neurologic disease in children.Host Paul Wirkus, MD, FAAP and guest Josh Bonkowsky, MD also examine the growing role of genomic testing, which is increasingly available in clinical practice and providing families with greater diagnostic clarity. Alongside these advances come important philosophical and ethical questions: What is the value of diagnosing a condition when no cure exists? How much information do families want, and how should that information be shared?Our guest discusses a “leveled results” approach to genomic testing, emphasizing shared decision-making and giving families meaningful input into how much information they receive. Throughout the episode, the focus remains on helping patients and families make informed decisions while navigating uncertainty with compassion and transparency.Have a question? Email questions@vcurb.com. Listener questions will be answered in episode four. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP. Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
We are continuing our series of interviewing thought leaders in the field of allergy and immunology. Dr. Gupta and Kortney sit down with Dr. Carla Davis, the president of the American Academy of Allergy, Asthma and Immunology. What we cover in this episode about Dr. Davis and the AAAAI What the AAAAI is and why it matters to patients. A 7,000-member organization working behind the scenes to support allergy and immunology care across the US and around the world. Dr. Davis's path to the presidency. From her early experiences advocating as a fellow to her major pivot from Baylor to Howard University, the journey that shaped her priorities. Initiative: AAAAI Advocate. A new platform connecting patients and physicians directly to their legislators, making it easy to share your story and push for better access to allergy care. Initiative: AAAAI AI Task Force. A dedicated group bringing AI tools into allergy care, including AAAAI Ignite, a Netflix-style platform that helps members find and curate personalized allergy content. Initiative: The Collaborative Translational Mechanistic Research Seed Award. A $100,000 grant pairing laboratory scientists with clinical allergists to move new discoveries directly into patient care. More resources American Academy of Allergy, Asthma and Immunology AAAAI Advocate platform Allergy & Asthma Network health equity resources This podcast is made in partnership with the Allergy & Asthma Network.
Tongue ties happen everywhere in the world and India is no exception. In this episode, Katie Oshita and Dr. Ankita Shah discuss what tongue tie care looks like in India today, the awareness, the gaps, and how one specialist is working to change the conversation. Listen to hear more about the unique challenges of diagnosis and treatment in India.Podcast Guest: Dr. Ankita Shah is an internationally trained airway-focused dentist, TMJ expert, and tongue tie specialist with 16 years of experience integrating sleep health, jaw rehabilitation, orthodontics, and myofunctional therapy.She holds several rare distinctions: India's first and only OC-trained TMJ expert in Gnatho-Neuromuscular dentistry (fewer than 200 practitioners hold this credential globally), and the first Indian Ambassador of The Breathe Institute, where she trained under renowned ENT and sleep surgeon Dr. Soroush Zaghi in Los Angeles. She also serves as President of the India Airway Co-LAB Chapter under the American Academy of Physiological Medicine and Dentistry.Podcast Host: Katie Oshita, RN, BSN, IBCLC has over 25 years of experience working in Maternal-Infant Medicine. While Katie sees clients locally in western WA, Katie is also a telehealth lactation consultant believing that clients anywhere in the world deserve the best care possible for their needs. Being an expert on TOTs, Katie helps families everywhere navigate breastfeeding struggles, especially when related to tongue tie or low supply. Katie is also passionate about finding the root cause of symptoms, using Functional Medicine practices to help client not just survive, but truly thrive. Email katie@cuddlesandmilk.com or www.cuddlesandmilk.com
Many Windows: Conversations on Ministry with Rev. Julie Taylor
Theology, love, and Howard Thurman are the focus of this conversation with my colleague, the Rev. Dr. Kathryn House.Link to the recording of Howard Thurman reading his work, “Meditations of the Heart,” part of the Howard Thurman Collection in the Howard Gotlieb Archival Research Center at Boston University Libraries https://digitallibrary.bu.edu/readings-meditations-heart-part-1-2Text referenced: Love at the Center: Unitarian Universalist Theologies, editor Rev. Dr. Sofía Betancourt https://uuabookstore.org/products/love-at-the-centerRev. Kathryn House, Ph.D., is Assistant Professor of Leadership Studies and Practical Theology and Chair of the Rev. Dr. Lee Barker Professorship of Leadership Studies at Meadville Lombard Theological School. She was previously Visiting Assistant Professor of Practical Theology and a Louisville Institute Postdoctoral Fellow at Louisville Presbyterian Theological Seminary. House received her BA in Religion from Duke University and her MDiv. and PhD in Theological Studies from Boston University School of Theology. House is ordained in the American Baptist Churches, USA and affiliated with the Alliance of Baptists.House is co-editor, with Dr. Sara Moslener, of "Purity Culture and its Discontents," a special issue of Theology and Sexuality. She has also contributed chapters to Trauma and Lived Religion: Transcending the Ordinary (Palgrave Macmillan) and Faithfully Feminist: Jewish, Christian, and Muslim Feminists on Why We Stay (White Cloud Press), and her writing has been published in journals such as Perspectives in Religious Studies, Pastoral Psychology, and American Baptist Quarterly. Her current book project, an expansion of her dissertation, The Afterlife of White Evangelical Purity Culture: Wounds, Legacies, and Impacts, investigates the theological scaffolding of white evangelical purity culture and its continuing impact on American religious and political life.Her teaching and scholarship are generated at intersections of leadership studies, trauma-informed pastoral and spiritual care, and liberation theologies. She serves on the steering committee for the Ecclesial Practices Unit of the American Academy of Religion and on the Advisory Committee of the Wabash Center for Teaching and Learning in Theology and Religion. She is also an active member of the National Association of Baptist Professors of Religion (NABPR) and NABPR Region-at-Large.__________________________Thank you for listening. Many Windows: Conversations on Ministry is a production of Meadville Lombard Theological School. Theme music is “Destination” by Justhea. This episode is produced by Jules Taylor.(Justhea: spoti.fi/2NycVfd and apple.co/3u51z2V)
This member-driven podcast is a benefit of membership of the Arizona Chapter of the American Academy of Pediatrics (AzAAP) and is intended for AzAAP pediatric healthcare members. No information or content in this podcast is intended to substitute or replace a consultation with a healthcare provider or specialist. All non-healthcare providers should reach out to their child's pediatrician for guidance. Music: Wallpaper by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/4604-wallpaperLicense: http://creativecommons.org/licenses/by/4.0/
This and all episodes at: https://aiandyou.net/ . I have been talking with Tomaso Poggio, Eugene McDermott professor in the Department of Brain and Cognitive Sciences at MIT and the Director of the Center for Brains, Minds, and Machines, and one of the founders of the field of computational neuroscience. Tomaso is a fellow of the American Academy of Arts and Sciences and of the American Association for the Advancement of Science, and a founding fellow of the Association for the Advancement of Artificial Intelligence. He develops models of brain function that illuminate human intelligence and builds intelligent machines that can mimic human performance His new book, Brains, Minds, Machines, The Mystery of Human Intelligence, the Enigmas of the Artificial, comes out this summer. We talk about learning in the brain and synaptic mechanisms, the role of sleep, what AI scientists should pay more attention to from neuroscience, other computational mechanisms in the brain besides neurons, connectomics, robotics, and… flies and worms. All this plus our usual look at today's AI headlines! Transcript and URLs referenced at HumanCusp Blog.
Heart disease is still the number one killer, and Dr. David Brownstein says the current approach is not working.In this episode of The Natural Heart Doctor Show, Dr.Brownstein joins Dr. Jack Wolfson to discuss food quality, iodine deficiency, thyroid health, fluoride exposure, statins, and why preventing heart attacks and strokes requires looking beyond prescriptions.- - - - - About the Guest:Dr. David Brownstein is a board-certified family physician and the Medical Director of the Center for Holistic Medicine in West Bloomfield, Michigan. A graduate of the University of Michigan and Wayne State University School of Medicine, he is a member of the American Academy of Family Physicians and serves on the board of the International College of Integrative Medicine.Dr. Brownstein is an internationally recognized speaker and the author of 17 books, including Iodine: Why You Need It, Why You Can't Live Without It. His work focuses on holistic medicine, thyroid health, iodine, natural hormones, nutrition, and helping patients address the underlying factors that contribute to chronic illness.Social Handles:Website: https://www.drbrownstein.com/Instagram: https://www.instagram.com/centerforholisticmedicine/- - - - -Jack Wolfson, DO, FACCWebsites: https://drjackwolfson.com/; https://naturalheartdoctor.com/LinkedIn: https://www.linkedin.com/in/drjackwolfsonReady to move past the confusion and fear of typical heart health approaches? Visit naturalheartdoctor.com/discovery to schedule your free discovery call and start your journey toward a 100-year heart with real, evidence-based answers.- - - - -PODCAST Thank you for listening. Please subscribe and share. This podcast is produced by DrTalks.com https://drtalks.com/podcast-service/
The Small Business Horsepower Podcast www.smallbusinesshorsepower.com
Dr. Michael Skyhar is a board-certified orthopedic surgeon specializing in sports medicine. He provides expert care for a wide range of orthopedic conditions and injuries, with particular expertise in knee and shoulder arthroscopy, rotator cuff repair, joint aspiration and drainage procedures, and other advanced surgical treatments. Dr. Skyhar's treatment philosophy emphasizes comprehensive, patient-centered care, combining both operative and non-operative approaches to orthopedic injuries and disorders. He is committed to pursuing conservative treatment options whenever appropriate while delivering precise surgical intervention when necessary to achieve the best possible outcomes. In addition to his clinical practice, Dr. Skyhar has published and presented numerous articles on sports medicine injuries and advancements in orthopedic care. He is an active member of the American Academy of Orthopaedic Surgeons, the American Orthopaedic Society for Sports Medicine, and the California Medical Association. He also previously served as Chief of Staff at Scripps Memorial Hospital Encinitas. Dr. Skyhar is dedicated to helping patients return to an active, healthy lifestyle through personalized treatment plans, advanced surgical techniques, and compassionate care.
DOCKET ALERTS: The Supreme Court rebuffed the Trump Administration's "emergency" request to revoke temporary protected status for half a million Haitian and Syrian nationals. It granted cert before judgment and set oral argument for April. The DOJ dropped charges against Jay Carey, a veteran who burned a flag in Lafayette Park to protest Trump's executive order purporting to ban flag-burning. In Massachusetts, Judge Brian Murphy blocked HHS Secretary Kennedy's attempt to rewrite the child and adult vaccine schedules. And the Justice Department keeps lowering the bar in an effort to get lawyers willing to sign on to burn down their reputations in service of the Trump agenda. MAIN SHOW: We discuss US Attorney for DC Jeanine Pirro's crashout over the implosion of her retaliatory investigation into Federal Reserve Chair Jerome Powell. Judge Boasberg quashed the subpoenas, saying that there was no reason at all to think Powell committed a crime. The Judicial Conference is making it slightly easier for criminal defendants to secure representation. They're also going to war with the General Services Administration, the world's worst landlord. The Live Nation trial continues, without the government. Andrew's got a deep dive into the Tunney Act and a similar antitrust case blown up by the Trump DOJ under pressure from well-connected lobbyists. These people made us agree with Laura Loomer — RUDE! TPS Cert Before Judgment https://www.supremecourt.gov/orders/courtorders/031626zr1_5h25.pdf US v. Carey [Flag burning] https://www.courtlistener.com/docket/71223464/united-states-v-carey American Academy of Pediatrics v. Kennedy [Vaccines] https://www.courtlistener.com/docket/70722326/american-academy-of-pediatrics-v-kennedy/ Judiciary Says Courthouses Are in Crisis, Seeks Real Property Authority https://www.uscourts.gov/data-news/judiciary-news/2026/02/24/judiciary-says-courthouses-are-crisis-seeks-real-property-authority US judiciary approves new public defender office focused on US Supreme Court advocacy https://www.reuters.com/legal/government/us-judiciary-approves-new-public-defender-office-focused-us-supreme-court-2026-03-10 DOJ to Allow Hiring of US Prosecutors Straight Out of Law School https://news.bloomberglaw.com/us-law-week/doj-to-allow-hiring-of-us-prosecutors-straight-out-of-law-school Law School Tells Students, 'You MUST Be Aligned Politically With President Trump,' For Summer Job https://abovethelaw.com/2026/03/law-school-tells-students-you-must-be-aligned-politically-with-president-trump-for-summer-job/ Jeanine Pirro Crashes Out https://www.lawandchaospod.com/p/jeanine-pirro-crashes-out In re Grand Jury Subpoenas [Jerome Powell] https://www.courtlistener.com/docket/72490330/in-re-grand-jury-subpoenas The Rule of Law Versus the Rule of Lobbyists [Roger Alford] https://assets.bwbx.io/documents/users/iqjWHBFdfxIU/rqWZHzWNbqZc/v0 Proposal to Give Judiciary Real Property Authority https://www.uscourts.gov/sites/default/files/document/judiciary-real-property-authority-legislative-package.pdf Show Links: https://www.lawandchaospod.com/ BlueSky: @LawAndChaosPod Threads: @LawAndChaosPod Twitter: @LawAndChaosPod
TODAY on the GWA Podcast is the esteemed painter Joan Snyder. Hailed for her large-scale gestural canvases that pulsate with colour, line and text, and are often layered with, buried in, or imploded with images of flowers, faces, or bodies, Snyder's all-encompassing works are nothing but electric. Sometimes large scale, with brushstrokes that populate the canvas like gemstones or musical scores with a whole range of keys: look at Snyder's work for a while, and it's like whole worlds emerge. Simultaneously soft but violent, beautiful yet aggressive, her works can evoke every season of emotion, just as she once wrote in her journal in 1972: "The strokes in my painting speak of my life and experiences. They are sometimes soft, they sometimes laugh, and are often violent. They bleed and cry. I speak of love and anguish, of fear, and mostly of hope." Born in 1940, Snyder came to art not straight away, but by chance during her studies at Rutgers University, when she was studying sociology in preparation for a career in social work. But it was under the mentorship of Billy Prichard that she pivoted to art, showing just how important teachers can be. Today we meet Joan in her Brooklyn studio, where she remains one of the legendary artists of her time. A recipient of a MacArthur Fellowship and an American Academy of Arts and Letters Award, and in museum collections all over the world, Snyder, at 85 – nearly 86 – is painting more than ever and this summer, will take to Paris for her upcoming show, Earthsongs at Thaddaeus Ropac Paris, and I cannot wait to find out more. Joan Snyder: Earthsongs opens 6 June at Thaddeus Ropac Paris https://ropac.net/exhibitions/796-joan-snyder-earthsongs/ THIS EPISODE IS GENEROUSLY SUPPORTED BY THE LEVETT COLLECTION: www.famm.com/en/ www.instagram.com/famm_mougins // www.merrellpublishers.com/9781858947037 Follow us: Katy Hessel: @thegreatwomenartists / @katy.hessel Sound editing by Tory Pope Co-produced with Molly LaFosse Music by Ben Wetherfield
Join Elevated GP: www.theelevatedgp.com Register for the live meeting: https://www.theelevatedgp.com/ElevationSummit Download the Injection Molding Guide: https://www.theelevatedgp.com/IMpdf What separates good veneer dentistry from truly exceptional aesthetic dentistry? In Part 2 of this in-depth conversation on Digital Dentist Digest, Dr. Melissa Seibert sits down with legendary prosthodontist and aesthetic dentistry educator Dr. Gerald Chiche to explore the clinical nuances, preparation strategies, and decision-making principles behind predictable porcelain veneer treatment. Dr. Chiche, former president of the American Academy of Esthetic Dentistry and internationally recognized leader in aesthetic dentistry, shares decades of experience performing veneers with a strong emphasis on minimally invasive preparation design, enamel preservation, and long-term restorative success. In this episode, Dr. Chiche walks through his additive veneer preparation workflow, including mock-up transfers, bisacryl matrices, depth-cut strategies, and techniques for staying predictably in enamel to maximize bond durability. He explains why preserving enamel remains one of the most important principles in adhesive dentistry and how thoughtful preparation design directly impacts the longevity of porcelain veneers. The conversation also covers gingival management, cord packing techniques, impression accuracy, proximal preparation design, and margin placement in aesthetic cases. Dr. Chiche shares practical clinical pearls for managing difficult scenarios such as tetracycline staining, dark preparations, black triangles, and patients requesting highly translucent veneers despite significant discoloration challenges. Beyond technique, this episode focuses heavily on clinical judgment and patient communication. Dr. Chiche discusses how to determine when veneers are the right treatment, when direct bonding may be a better option, and how informed consent and expectation management are essential in elective cosmetic dentistry. He also explains why collaboration with skilled ceramists and careful mock-up evaluation remain foundational to achieving natural, long-lasting aesthetic results. This episode is ideal for general dentists, cosmetic dentists, prosthodontists, and clinicians interested in porcelain veneers, smile design, adhesive dentistry, and minimally invasive aesthetic treatment planning. Whether you are refining your veneer workflow or looking to strengthen your understanding of aesthetic case selection, this conversation offers practical insights grounded in decades of clinical excellence and evidence-based dentistry.
Episode 420: On the night of March 1st, 1895, in the paymaster's office of the Montreal Cotton Company in Valleyfield, Quebec, a twenty-year-old Irish immigrant named Francis Valentine Cuthbert Shortis shot three men — killing two of them and leaving the third for dead in the darkness of the mill floor. What followed was the longest murder trial in Canadian history, a psychiatric battle that divided the country's leading medical minds, and a political crisis that reached the cabinet of Prime Minister Mackenzie Bowell and the desk of the Governor General himself. The victims were John Loy, twenty-four years old, and night watchman Maxime Leboeuf, who left behind a widow and five children. The survivor was Hugh Wilson, who carried the consequences for the rest of his life. Sources:Valentine Shortis Case | thecanadianencyclopedia.caThe Queen vs. F.V.C. Shortis (microform)| Internet ArchiveThe Case of Valentine Shortis — University of Toronto Press / Amazon.caValentine Shortis Case — The Canadian EncyclopediaThe Canadian Trial of the Century: The Story of 'Cracked Shortis' — History IrelandThe Case of Valentine Shortis — Yesterday and Today — PubMedForensic Psychiatry in Canada — Journal of the American Academy of Psychiatry and the LawMontreal Gazette Trial Coverage, October 25, 1895 — Newspapers.comProfile: Author-Professor Martin Friedland — Bill Gladstone GenealogyMontreal Cotton Company — History of the Mill at Valleyfield — MUSO Virtual MuseumManitoba Schools Question — Dictionary of Canadian BiographyMontreal Cotton Company Mills — Library and Archives CanadaSir Donald Macmaster, Crown Prosecutor — WikipediaJ.N. Greenshields, Lead Defence Counsel — Americana AristocracyHenri St. Pierre, Defence Counsel — 76th New York State Volunteers Learn more about your ad choices. Visit megaphone.fm/adchoices